WSA 2009
(Jul. 18-20, 2009, Beijing, China)
CMBF 2009
(Aug. 8-10, 2009, Dalian, China)
IDDST 2009
(Oct.22-25, 2009, Shanghai, China)
CEMD 2009
(Nov.19-21, 2009, Beijing, China)
WCG 2009
(December 1-7, 2009, Foshan, China)
PepCon 2010
(March 21-23, 2010, Beijing, China)
ICA 2010
(Mar. 24-26, 2010, Beijing, China)
WCV 2010
(March 24-26, 2010, Beijing, China)
WCC2010
Tri-Breast Cancer Conference

(Apr.25-27, 2010, Shanghai, China)
IBIO 2010
(July 25-27, 2010, Qingdao, China)
 
   Scientific Program

BIT Life Sciences' 2nd World Cancer Congress
Full Program
Theme: Gateway to Future Medicine

Time: June 22-25
Venue: Beijing International Convention Center (BICC), Beijing, China

NOTE: WCC 2009 is comprised of Six Tracks and Two Workshops designed to offer comprehensive sessions that address current issues in cancer area from basic research to clinical therapy. You can register a whole conference or select a single track or register for special service package that you want for your participation. Now the program is under developing from viewing submitted abstracts. Proposed topics or related as below are accepted.

LANGUAGE NOTE: This meeting will be conducted in English.

Main Conference
Opening Ceremony and Keynote Forum

Time and Place

Activities

June 22, 2009
Monday
08:20-11:45

Opening Ceremony

08:20-08:40

Group Photo (Place: Gate of BICC)

09:00-09:05

Chair' s Opening Remark

09:05-09:35

VIP' s Address

Keynote Forum: Scientific Innovations for Future Anticancer Medicine

09:40-10:05

Title: A Century of Deciphering the Control Mechanisms of Sex Steroid Action in Breast and Prostate Cancer: The Origins of Targeted Therapy and Chemoprevention
Dr. Virgil Craig Jordan,
Vice President and Scientific Director for Medical Science, Fox Chase Cancer Center, USA

10:05-10:30

Title: The Real Challenges of Tomorrow Oncology: Early Diagnosis and Individualized Treatment in Cancer Patients
Dr. Thomas Tursz,
Professor and General Director, Institute Gustave Roussy; President of the French Federation of Comprehensive Anticancer Centres (FNCLCC), France

10:30-10:55

Keynote Lecture Three: Speech Delivered by Domestics Expert

10:55-11:20

Title: Molecular Imaging in Targeted Oncology Drug Development
Dr. Ai-Min Hui,
Medical Director, Clinical Research Oncology, Cephalon, Inc., USA

11:20-11:45

Title: New Challenges for Targeted Nanoparticles: From Cancer Stem Cells to “Theranostics”
Dr. Gregg B. Fields, President Elect of American Peptide Society; Professor, Department of Biochemistry, University of Texas Health Science Center, San Antonio, USA
June 22, 2009
Monday
18:00-21:00
Welcome Banquet and Art Performance

Track 1: Medical Research on Major Cancers
-Toward Understanding Individual Cancer

Time and Place

Co-Current Sessions and Activities

June 22, 2009
Monday
13:30-17:00

Track 1-1: Gynecological Cancers: Breast Cancer vs Ovarian Cancer (Part 1)Click here for Poster   click here Part 2

Session Chair:

Dr. Andrew R Collins, Professor, Genetic Epidemiology and Bioinformatics, Human Genetics Research Division, University of Southampton, Southampton General Hospital, UK

Session Co-Chair:
Dr. Zhiyuan Hu, Director, Rapid Adoption Molecular Lab, University of North Carolina Hospital, USA

13:30-13:50

Keynote Speech:
Title: The Value of Translational Research in the Discovery and Development of Lapatinib
Dr. Wenle Xia
, Associate Professor and Director of Duke Oncology Translational Research Lab, Duke Comprehensive Cancer Research Center, Duke University, USA

13:50-14:10

Title: Genetic Dissection of Breast Cancer Phenotypes
Dr. Andrew R Collins
, Professor, Genetic Epidemiology and Bioinformatics, Human Genetics Research Division, University of Southampton, Southampton General Hospital, UK

14:10-14:30

Title: Enolase, An NFkB and Estrogen Receptor a-regulated Gene that Confers Tamoxifen-induced Resistance in Human Breast Cancer Cells
Dr. Chih-Hsiung Wu, Professor and Superintendent, Department of Surgery, Taipei Medical University Hospital, Taipei Medical University, Taiwan

14:30-14:50

Title: Stroma Modulates Growth and Response to ChemotherapyI in Ovarian Cancer
Dr.
J. Rebecca Liu, Associate Professor, Division of Gynecologic Oncology; Department of Obstetrics and Gynecology, University of Michigan Comprehensive Cancer Center, USA

14:50-15:10

Title: MicroRNAs in Breast and Endometrium
Dr. Constance Albarracin
,
Associate Professor, Department of Pathology, The University of Texas; MD Anderson Cancer Center

15:10-15:25

Coffee Break

15:25-15:45

Title: Application of Intrinsic Subtype Classification of Breast Cancer in Clinical Practice
Dr. Zhiyuan Hu, Director, Rapid Adoption Molecular Lab, University of North Carolina Hospital, USA

15:45-16:05

Title: Morphoproteomic Confirmation of a Constitutively Activated mTOR Pathway in Gynecologic Malignancy
Dr. Xiuzhen Duan,
Assistant Professor of Pathology & Laboratory Medicine, The University of Texas Medical School at Houston, USA

16:05-16:25

Title: Inhibition of Ovarian Cancer Growth by Antiprogestins
Dr. Carlos Telleria,
Associate Professor of Biomedical Sciences, Associate Professor of Obstetrics and Gynecology, Sanford School of Medicine, University of South Dakota, USA

16:25-16:45

Title: Treatment of Breast Cancer during Pregnancy: What Evidence Do We Have?
Dr. Hatem A. Azim Jr, Department of Medical Oncology, National Cancer Institute, Cairo, Egypt

16:45-17:05

Title: Mechanical Stress Signaling in Breast Cancer Progression
Dr. Josh Wang,
Research Fellow, BC Cancer Agency's Trev & Joyce Deeley Research Centre, Canada

17:05-17:25

Title: Wine, Liquor, Beer and Risk of Breast Cancer in a Large Population
Dr. Yan Li,
Senior Physician, Kaiser Permanente Medical Center, USA

June 22, 2009
Monday
13:30-17:00

Track 1-2: Lung and Bronchus Cancer

Session Chair:

Dr. Yuhchyau Chen, Professor, Department of Radiation Oncology, University of Rochester Medical Center, USA
Session Co-Chair:
Dr. Vladimir Lazar, Head of  Functional Genomics, Head of Integrated Biology Platform and R&D, Institut Gustave Roussy, France

13:30-13:50

Keynote Speech:
Speech Opportunity Available

13:50-14:10

Title: Taxane-based Chemoradiotherapy for Local and Distant Metastasis Control of Stage III Non-small Cell Lung Cancer
Dr. Yuhchyau Chen, Professor, Department of Radiation Oncology, University of Rochester Medical Center, USA

14:10-14:30

Title: Intensity Modulated Radiation Therapy (IMRT) for Treatment of a Moving Lung Tumor Resulting from Respiration
Dr. Andrew Wu,
Professor, Department of Radiologic Sciences, Thomas Jefferson University, Philadelphia, PA, USA

14:30-14:50

Title: Tailor-made Chemotherapy and Chemo-gene Therapy Based on Genetic Analyses in Non-small Cell Lung Cancer
Dr. Cheng-long Huang, Associate Professor, Second Department of Surgery, Kagawa University, Japan

14:50-15:10

Title: ProGRP - A Marker for Small Cell Lung Cancer
Dr. Rahul D Patil, Product Manager, Abbott Laboratories, Diagnostics Division, Illinois, USA

15:10-15:25

Coffee Break

15:25-15:45

Title: The System Biology Approach of Chemores Consortium to Decipher Resistance to Chemotherapy of Lung Cancers
Dr. Vladimir Lazar,
Head of  Functional Genomics, Head of Integrated Biology Platform and R&D, Institut Gustave Roussy, France

15:45-16:05

Title: Phosphodiesterases in Cancer
Dr. Ralph T. Schermuly, Professor, Max-Planck-Institute for Heart and Lung Research, Research Group Leader of "Lung Vascular Remodeling and Anti-Remodeling"; Member of the Board of Directors of the University of Giessen Lung Center (UGLC), Germany  

16:05-16:25

Title: Neuroendocrine Tumors of the Lung: Update on Molecular Pathology
Dr. Haodong Xu,
Associate Professor, Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, USA

16:25-16:45

Title: Nonpeptide Macrocyclic Histone Deacetylase Inhibitors for Targeted Lung Cancer Treatment
Dr. Yomi Oyelere,
Assistant Professor, School of Chemistry & Biochemistry, Georgia Institute of Technology, USA

16:45-17:05

Title: Sniffing Out Lung Cancer from Real Breath Samples by Means of Nanomaterial-based Artificial Olfactory System
Dr. Hossam Haick,
Assistant Professor, Department of Chemical Engineering, Russell Berrie Nanotechnology Institute, Israel

17:05-17:25

Title: Diagnostic Strategies of Lung Cancer
Dr. Anant Mohan, Assistant Professor of Medicine, Department of Medicine, All India Institute of Medical Sciences, India

17:25-17:45

Title: Lung Cancer in Women
Dr. Elzbieta Radzikowska, Associate Professor, National Tuberculosis and Lung Diseases Research Institute, Poland

June 23, 2009
Tuesday
08:30-12:00

Track 1-3: Gastrointestinal Cancers

Session Chair:

Dr. J. F. Geschwind, Professor of Radiology, Surgery and Oncology & Director, Vascular and Interventional Radiology, Johns Hopkins University School of Medicine, USA
Session Co-Chair:

Dr. Mei. X. Wu, Associate Professor, Wellman Center for Photomedicine, MGH/Harvard Medical School, USA

08:30-08:50

Title: Stem Cell and Cancer Stem Cell Regulation in Adult Drosophila Kidney
Dr. Steve Hou, Senior Investigator, Mouse Cancer Genetics Program, National Cancer Institute, National Institutes of Health, USA

08:50-09:10

Title: Loco-regional Therapy for Liver Cancer
Dr. J. F. Geschwind, Professor of Radiology, Surgery and Oncology & Director, Vascular and Interventional Radiology, Johns Hopkins University School of Medicine, USA

09:10-09:30

Speech Opportunity Available

09:30-09:50

Title: Identification of Novel Gastrointestinal Cancer Genes Using a Transposon-based Screen in Mice
Dr. Robert Cormier,
Medical School Duluth, University of Minnesota, USA

09:50-10:10

Title: Complete Response to Neoadjuvant Therapy for Esophageal Cancer – To Operate or not to Operate?
Dr. Hanoch Kashtan,
Professor and Head, Department of Surgery, Kaplan Medical Center, Israel

10:10-10:25

Coffee Break

10:25-10:45

Title: A Serological Proteome-based Identification of Antigens of Therapeutic Value in Pancreatic Carcinoma
Dr. Francesco Novelli
, Professor and Immunology, Center for Experimental Research and Medical Studies (CERMS), University of Turin, San Giovanni Battista Hospital, Italy

10:45-11:05

Title: Epigenetic Regulation of Irradiation and Stress -Induced Pro-apoptotic Gene Expression
Dr.
Lei Zhou,
Associate Professor, Department of Molecular Genetics and Microbiology, Member, UF Shands Cancer Center, College of Medicine, University of Florida, USA

11:05-11:25

Title: Transient Production of IL-17 Protects the Colon from Cancer Development
Dr. Mei. X. Wu,
Associate Professor, Wellman Center for Photomedicine, MGH/Harvard Medical School, USA

11:25-11:45

Title: Profiling of the Action Mechanisms and Molecular Targets of Novel Chemotherapeutics Derived from Herbal Source in Gastrointestinal Cancer
Dr. Joshua Ko,
Associate Professor, Pharmacology and Toxicology Laboratory, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China

11:45-12:05

Title: On the Edge between Chronic Infection and Stomach Cancer: Helicobacter PYLORI and Gastric Remodeling
Dr. Steven R. Blanke,
Associate Professor, Department of Microbiology, Institute for Genomic Biology, School of Molecular and Cellular Biology, University of Illinois, USA

12:05-12:30

Title: The Endogastric Capsule, a Screening Tool for the Early Diagnosis of Gastric Cancer through DNA Molecular Analyses
Dr.
Pietro Muretto,
Pathologist, Department of Pathology, Ospedale S. Salvatore, Italy

June 23, 2009
Tuesday
08:30-12:00

Track 1-4: Prostate Cancer
-Session Closed, But Poster Opportunity is Still Available. Click here for Poster

Session Chair:

Dr. Zongbing You, Assistant Professor, Department of Structural & Cellular Biology, Tulane Cancer Center, Louisiana Cancer Research Consortium; Tulane Center for Aging, Tulane University School of Medicine, New Orleans, Louisiana, USA

Session Co-Chair:

Dr. Youqiang Ke, Professor & Director in Molecular Pathology, School of Cancer Studies, The University of Liverpool, UK

08:10-08:30

Keynote Speech:
Title: Role of Reactive Oxygen Species (ROS) in MT1-MMP Induced Epithelial- mesenchymal Transition in Prostate Cancer
Dr. Stanley Zucker,
Professor, Department of Medicine, Stony Brook University, USA

08:30-08:50

Title: Identification of Genes Involved in Malignant Progression of Prostate Cancer
Dr. Youqiang Ke,
Professor & Director in Molecular Pathology, School of Cancer Studies, The University of Liverpool, UK

08:50-09:10

Title: Potential Therapeutic Use of a Fungus Derivative on Androgen Refractory Prostate Cancer
Dr. Yongchuan Wong,
Professor, Department of Anatomy and Cancer Research Centre, The University of Hong Kong, Hong Kong, China

09:10-09:30

Title: Does Hypoxia Contribute to the Failure of Androgen Ablation Therapy in Prostate Cancer?
Dr. Stephanie R. McKeown,
Professor, School of Biomedical Sciences, University of Ulster, Coleraine Co. Londonderry, Northern Ireland

09:30-09:50

Title: Mechanisms of Therapeutic Resistance in Prostate Cancer
Dr. Yun Qiu,
Associate Professor, Department of Pharmacology & Experimental Therapeutics, School of Medicine, University of Maryland, Baltimore, USA

09:50-10:10

Title: The Molecular Pathology of Prostate Cancer in a Chinese-predominant Population
Dr. Kakoli Das, Research Fellow, Cancer Science Institute and Department of Pathology, National University of Singapore, National University Health System, Singapore

10:10-10:25

Coffee Break

10:25-10:45

Title: IL-17, Inflammation and Cancer
Dr. Zongbing You, Assistant Professor, Department of Structural & Cellular Biology, Tulane Cancer Center, Louisiana Cancer Research Consortium; Tulane Center for Aging, Tulane University School of Medicine, New Orleans, Louisiana, USA

10:45-11:05

 

Title: The Role of Indoleamine 2, 3-Dioxygenase (IDO) Expression and Function in Prostate Cancer
Dr. Maurizio Provenzano, Head, Urological Research and Laboratory for Urologic Oncology, Clinic of Urology and Division of Surgical Research, University and University Hospital, Switzerland

11:05-11:25

 

Title: Polycyclic Aromatic Compound Benzo(a)Pyrene and Metabolites in CD1 Mouse Prostate
Dr. Olugbemiga B. Ogunkua,
Assistant Professor of Cancer Biology, Divisions of Cancer Biology and Professional Education, Department of Biomedical Sciences, Meharry Medical College, Nashville, USA

11:25-11:45

Title: Prostate Cancer Biomarkers in Ethnically Diverse Populations
Dr. Jun Luo, Assistant Professor of Urology and Oncology, Department of Urology, Johns Hopkins Hospital, USA

11:45-12:05

Title: Identification of a PTEN Negative Regulator during Prostate Tumorigenesis Using a Functional Screen
Dr. Damu Tang,
Associate Professor, Department of Medicine, McMaster University, Hamilton, Canada

12:05-12:25

Title: Effect of Herbal Compounds on Prostate Cancer
Dr. J. Arunakaran,
Senior Lecturer, Department of Endocrinology University of Madras, India

June 23, 2009
Tuesday
13:30-17:00

  Track 1-5: Colorectal and Colon Cancer

Session Chair:

Dr. Ooi Boon Swee, Associate Professor and Director, Minimally Invasive Surgery, Department of Colorectal Surgery, Singapore General Hospital, Singapore

Co-Chair:
Dr. Cesar Sze-Chuen Wong, Assistant Professor, Department of Clinical Oncology, Faculty of Medicine, Hong Kong Cancer Institute and Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China

13:30-13:50

Title: Laparoscopic Surgery for Rectal Cancer: Evidence from Hong Kong Trials
Dr. Simon S. M. Ng, Associate Professor, Division of Colorectal Surgery, Department of Surgery, The Chinese University of Hong Kong, China

13:50-14:10

Title: Genetic Alterations in Sporadic and Hereditary Colorectal Cancer: Implications for Molecular Diagnostics
Dr. Damjan Glavač, Professor of Human Genetics, Department of Molecular Genetics, Faculty of Medicine, University of Ljubljana, Slovenia

14:10-14:30

Title: Targeting Colorectal Cancer Stem Cells May Improve Survival
Dr. Edward H Lin,
Associate Professor of Medicine, University of Washington School of Medicine; Associate Member, Fred Hutchinson Cancer Research Center, USA

14:30-14:50

Title: Minimally Invasive Surgery for Colorectal Cancer: Can We Do Better?
Dr. Ooi Boon Swee, Associate Professor, Director, Minimally Invasive Surgery, Department of Colorectal Surgery, Singapore General Hospital, Singapore

14:50-15:10

Title: Laparoscopic Rectal Resection With Anal Sphincter Preservation For Rectal Cancer - Long Term Outcome
Dr. Mahajna Ahmad, Assistant Clinical Professor, Department of General Surgery A, Rambam Medical Center, Haifa, Israel

15:10-15:25

Coffee Break

15:25-15:45

Title: A Refined Immunomagnetic Enrichment Assay to Detect Cytokeratin 20 - Positive Circulating Tumor Cells in Patients with Colorectal Cancer
Dr. Cesar Sze-Chuen Wong
, Assistant Professor, Department of Clinica Oncology, Faculty of Medicine, Hong Kong Cancer Institute and Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China

15:45-16:05

Title: Colorectal Cancer Screening: Opyical Colonoscopy vs. CT Colonography and Colon Capsule Endoscopy
Dr. Zvi Fireman, Associate Professor of Medicine and Head, Gastroenterology Department, Hillel Yaffe Medical Center, Hadera, Israel

16:05-16:25

Title: Oncologic Results and Prognostic Factors after Multimodality Treatment of Locally Advanced Rectal Cancer
Dr.
Luca Stocchi,
Staff Surgeon, Department of Colorectal Surgery, Cleveland Clinic, Cleveland, USA

16:25-16:45

 

Title: Hereditaryand Familial Colorectal Cancers - Lynch Syndrome (HNPCC) and Familial Colon Cancer Type X
Dr. Wael Abdel-Rahman
, Senior Scientist, Department of Medical Laboratory Technology, College of Health Sciences, University of Sharjah, United Arab Emirates

16:45-17:05

Title: We Don’T Need Randomized Trials to Assess Cancer Surgical Procedures
Dr. Ned Abraham,
Senior Lecturer (Surgery), Coffs Harbour Health Campus, Faculty of Medicine, University of New South Wales, Australia

17:05-17:30

Speech Opportunity Available

June 23, 2009
Tuesday
13:30-17:00

Track 1-6: Neuro-Oncology, Head and Neck Tumors
-Session Closed, But Poster Opportunity is Still Available. Click here for Poster

Session Chair:
Dr. John Laterra, Professor of Neurology, Oncology, and Neuroscience, The Johns Hopkins School of Medicine and The Kennedy Krieger Research Institute, USA
Co-Chair:
Dr. Dikoma C Shungu, Professor, Department of Radiology, Weill Medical College of Cornell University, USA

13:30-13:50

Title: DNA Repair and Signaling in Alkylating Drug Induced Cell Death: Implications for Glioma and Melanoma Therapy
Dr. Bernd Kaina, Professor of Toxicology, Department of Toxicology, University of Mainz, Germany

13:50-14:10

Title: Primary Brain Malignancies: From Oncogenic Mechanisms to New Therapeutics
Dr. John Laterra, Professor of Neurology, Oncology, and Neuroscience, The Johns Hopkins School of Medicine and The Kennedy Krieger Research Institute, USA

14:10-14:30

Title: Extracellular Acidity in Tumors: A Phenomenon that Aids Tumor Growth, that Can be Used to Target Drugs, and Involves Target Proteins
Dr. Jonathan A. Coles, Centre for Biophotonics, Strathclyde Institute for Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK

14:30-14:50

Title: Prognostic Factors and Outcome after Salvage Treatment of Recurrent Nasopharyngeal Carcinoma
Dr. Daniel Chua,
Associate Professor, Department of Clinical Oncology, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China

14:50-15:05

Coffee Break

15:05-15:25

Title: Combination Treatment with Arsenic Trioxide and Irradiation Enhances Autophagic Effects in Glioma Cells through Increased Mitotic Arrest and ERK1/2 Signaling Pathways
Dr. Ying-Jan Wang, Associate Professor, Department of Environmental and Occupational Health, National Cheng Kung University Medical College, Taiwan

15:25-15:45

Title: Serial Intensity Modulated Radiotherapy/Radiosurgery in the Treatment of CNS and Head and Neck Neoplasms
Dr. Mario Ammirati
, Professor of Neurosurgery and Radiation Oncology; Director of Skull Base Neurosurgery; Director of Stereotactic Radiosurgery; Director, Dardinger Microneurosurgical Skull Base Laboratory, Department of Neurosurgery, Ohio State University, USA

15:45-16:05

Title: 1H Magnetic Resonance Spectroscopic Imaging Detection of Elevated Total Creatine as a Potential Biomarker of Brain Cancer
Dr. Dikoma C Shungu, Professor of Physics in Radiology, Weill Medical College of Cornell University, USA

16:05-16:25

Title: Clinical and Molecular Predictors of Prognosis in Childhood Ependymoma
Dr. Juliette Hukin,
Clinical Assistant Professor, Department of Pediatrics, University of British Columbia, Canada

16:25-16:45

Title: Advanced MRI Techniques in the Diagnosis and Management of Primary Brain Tumors
Dr. Timothy J. Kaufmann,
Assistant Professor, Department of Radiology, Mayo Clinic, USA

16:45-17:05

Title: Establishment of a Highly Invasive Human Glioblastoma Orthotopic Mouse Model with Properties of Real-time Imaging
Dr. Qian Xie, Research Scientist, Laboratory of Molecular Oncology, Van Andel Research Institute, USA

17:05-17:30

Title: The Role of Functional Imaging in Advanced Radiotherapy of Brain Tumors
Dr. Rafal Tarnawski, Professor, Department of Radiotherapy, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland

June 24, 2009
Wednesday
08:30-12:00

Track 1-7: Non-Hodgkin' s Lymphoma and Perspectives in Melanoma

Session Chair:

Dr. X. Frank Zhao, Director, Hematopathology Laboratory, University of Maryland School of Medicine, USA

Co-Chair:
Dr. Robert Andtbacka, Assistant Professor, Department of Surgery, University of Utah, The Huntsman Cancer Institute, USA

08:30-08:50

Title: Extracutaneous Melanoma in Sun Shielded Body Sites
Dr. Boel Ragnarsson-Olding
, Chief Physician, Department of Oncology(Radiumhemmet), Karolinska Institute/ Karolinska University Hospital, Sweden

08:50-09:10

Title: Lymph Node Surgery in Malignant Melanoma
Dr. Merlin Guggenheim
, Consultant, Division of Plastic and Reconstructive Surgery, Department of Surgery, University Hospital Zurich, Switzerland

09:10-09:30

Title: Phospho-p70S6K and cdc2/cdk1 are Novel Molecular Targets for Diffuse Large B-cell Lymphoma Combination Therapy
Dr. Xianfeng Frank Zhao, Director, Hematopathology Laboratory, University of Maryland School of Medicine, USA

09:30-09:50

Speech Opportunity Available

09:50-10:10

Title: Uveal Melanoma: New Findings and Possible New Therapy Strategies
Dr. Alexandre Nakao Odashiro,
Professor, Federal University of Mato Grosso do Sul, Campo Grande, MS, Brazil; Research Fellow, The Henry C Witelson Ocular Pathology Laboratory, McGill University, Montreal, Canada

10:10-10:25

Coffee Break

10:25-10:45

Title: The Impact of Sentinel Lymph Node Tumor Burden in Malignant Melanoma
Dr. Robert Andtbacka, Assistant Professor, Department of Surgery, University of Utah, The Huntsman Cancer Institute, USA

10:45-11:05

Speech Opportunity Available

11:05-11:25

Title: An Overview of the Diagnostic Challenges and Classification of Cutaneous T Cell Lymphomas
Dr. Mark Podberezin, Resident (PGY-3), Pathology Residency Program, University of Illinois at Chicago, USA

11:25-11:45

Speech Opportunity Available

11:45-12:05

Speech Opportunity Available

12:05-12:25

Panel Discussion
3-5 Topics will be Proposed by Session Chair

June 24, 2009
Wednesday
08:30-12:00

Track 1-8: Pancreatic Cancer
Session Chair:
Dr. Si Young Song, President of Korean Society of Gastrointestinal Cancer, Professor of Internal Medicine; Professor of Pharmacology, Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Korea
Co-Chair:
Dr. Nader Hanna, Chief, Surgical Oncology, Associate Professor of Surgery, University of Maryland Medical Center, USA

08:30-08:50

Call for Keynote Speaker

08:50-09:10

Title: Pancreatic Cancer: Advances, Controversies and Evidence-based Multimodality Therapy
Dr. Nader Hanna,
Chief, Surgical Oncology, Associate Professor of Surgery, University of Maryland Medical Center, USA

09:10-09:30

Speech Opportunity Available

09:30-09:50

Title: Clinical Prospect of Pancreatic Cancer: Challenge and Opportunity
Dr. Chunyou Wang,
Professor, Pancreatic Center, Union Hospital, Wuhan, Hubei Province, China

09:50-10:10

Speech Opportunity Available

10:10-10:25

Coffee Break

10:25-10:45

Title: CD44, Putative Cancer Stem Cell Marker, Positive Cells are Responsible for Acquiring Gemcitabine Resistnace in Pancreatic Cancer Cells
Dr. Si Young Song, President of Korean Society of Gastrointestinal Cancer, Professor of Internal Medicine; Professor of Pharmacology, Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Korea

10:45-11:05

Title: Current Diagnosis and Treatment of Pancreatic Cystic Neoplasms
Dr. Bulent Salman
, Department of General Surgery, HPB Surgery Division, Gazi University School of Medicine, Ankara, Turkey

11:05-11:25

Speech Opportunity Available

11:25-11:45

Speech Opportunity Available

11:45-12:05

Speech Opportunity Available

12:05-12:25

Panel Discussion
3-5 Topics will be Proposed by Session Chair

June 24, 2009
Wednesday
13:30-17:00

Track 1-9: Skin Cancer

Session Chair:
Call for Host
Session Co-Chair:
Dr. Yinling Hu, Principle Investigator, Cancer and Inflammation Program, National Cancer Institute, National Institutes of Health, USA

13:30-13:55

Keynote Speech:
Title:
A Novel Nutrient-based Approach in Controlling Metastasis and other Key Mechanisms of Cancer
Dr. Aleksandra Niedzwiecki, Member of the Board of the Dr. Rath Health Foundation, The Executive Vice President and Vice President of Research at Matthias Rath, Inc., CA, USA

13:55-14:20

Speech Opportunity Available

14:20-14:45

Title: IKKa is Required to Maintain Skin Homeostasis and Prevent Skin Cancer
Dr. Yinling Hu, Principle Investigator, Cancer and Inflammation Program, National Cancer Institute, National Institutes of Health, USA

14:45-15:10

Speech Opportunity Available

15:10-15:25

Coffee Break

15:25-15:50

Title: The Importance of Stromal Matrix in the Development and Treatment of Skin Cancer
Dr. Hugo Drago,
Professor, Burns Hospital, Buenos Aires City, Argentina

15:50-16:15

Title: Epigenetic Alterations in Skin Melanoma and Borderline Melanocytic Lesions
Dr. Stefania Staibano,
Associate Professor of Pathology, Department of Biomorphological and Functional Sciences, Pathology Section, University "Federico II" of Naples, Italy

16:15-16:40

Title: The Incidence and Mortality of Cutaneous Melanoma in Bulgaria
Dr. Petranka Troyanova,
Associate Professor, and Executive Director National Oncological Hospital, Bulgaria

16:40-17:05

Speech Opportunity Available

17:05-17:25

Panel Discussion
3-5 Topics will be Proposed by Session Chair

June 25, 2009
Thursday
08:30-12:00

Track 1-10: Leukemia, and Myelodysplasia

Session Chair:

Dr. William L. Carroll, Julie and Edward J. Minskoff Professor of Pediatrics and Director, NYU Cancer Institute; Chief, Division of Pediatric Hematology/Oncology, Stephen D. Hassenfeld Children's Center, USA

Co-Chair:
Call for Co-Host

08:30-08:55

Title: Genomics and Childhood Leukemia
Dr. William L. Carroll, Julie and Edward J. Minskoff Professor of Pediatrics and Director, NYU Cancer Institute; Chief, Division of Pediatric Hematology/Oncology, Stephen D. Hassenfeld Children's Center, USA

08:55-09:20

Title: Standardization and External Quality Controls for Innovative Molecular Diagnostic Kits in the Clinic: Lessons from BCR ABL Dosage in the Tyrosine Kinase Inhibitors Era
Dr. Jean Gabert
, Professor of Biochemistry and Molecular Biology, Head of the Department at the University Hospital in Marseilles; Head of the UMAGT ( Methodological Unit for Global Analysis of the Transcriptome), France

09:20-09:45

Title: DNA Methylation Profiling in Paediatric Acute Lymphoblastic Leukaemia
Dr. Richard Saffery,
Group Leader and Senior Research Fellow, Developmental Epigenetics, Murdoch Childrens Research Institute, Australia

09:45-10:10

Title: Should We Transplant Old Patients with Acute Myeloid Leukemia?
Dr. Alexandros Spyridonidis, Associate Professor, BMT Unit, Hematology Division, Patras University Hospital, Greece

10:10-10:25

Coffee Break

10:25-10:50

Title: Genetic Instability in B Cell Lneage Acute Lymphoblastic Leukemia
Dr. Markus Müschen, Hugh Colvin Chair in Cancer Research and Director, Leukemia and Lymphoma Program, Norris Comprehensive Cancer Center, University of Southern California, USA

10:50-11:15

Title: Imatinib-loaded Polymer Capsules for Increased Targeting of BCR/ABL+ Leukemia Cells
Dr. Stefano Leporatti, Senior Researcher (Primo Ricercatore CNR, II Livello), National Nanotechnology Laboratory (NNL) of CNR-INFM Distretto Tecnologico, Italy

11:15-11:40

Title: Drug Efflux Pumps: Cause of Resistance against Conventional and New Drugs for Leukemia
Dr. Daniel Steinbach, Lecturer, Department of Pediatrics, University Children's Hospital Ulm, Germany

11:40-12:05

Title: Cytokines Play a Role in the mTOR Signaling Pathway in Kasumi-1 Leukemia Cell Line
Dr. Nawfal I Ismail,
Advanced Medical and Dental Institute, Malaysia

12:05-12:30

Panel Discussion
3-5 Topics will be Proposed by Session Chair

June 24, 2009
Wednesday
13:30-17:00

Track 1-11: Gynecological Cancers: Breast Cancer vs Ovarian Cancer(Part 2)  click here Part 1
-Session Closed, But Poster Opportunity is Still Available. Click here for Poster

Session Chair:
Dr. Dimcho Bachvarov, Professor, Department of Medicine, Laval University, Quebec, Canada
Co-Chair:
Dr. Weizhu Zhu, Research Assistant Professor, Department of Surgery, University of North Dakota, USA

13:30-13:50

Title: Modification of BRCA1/2-associated Breast Cancer Risk by /BRCA1/2/ Interacting Genes
Dr. Shannon Chuai,
Group Leader/Triage Manager, Biostatistics Analysis Center (BAC), CCEB, University of Pennsylvania School of Medicine, USA

13:50-14:10

Title: Targeting the PI3K/AKT Signaling Pathway in Breast Cancer
Dr. Qing-Bai She, Senior Research Scientist, Program in Molecular Pharmacology and Department of Medicine, Memorial Sloan-Kettering Cancer Center, USA

14:10-14:30

Title: Molecular Determinants of Ovarian Cancer Chemoresistance
Dr. Dimcho Bachvarov,
Professor, Department of Medicine, Laval University, Quebec, Canada

14:30-14:50

Title: Atip3 is A Novel Tumor Suppressor and Potential Therapeutic Target in Breast Cancer
Dr. Clara Nahmias,
Research Director, Department of Cell Biology, Institute Cochin, University Paris Descartes, France

14:50-15:10

Title: Altered MicroRNA Expression Induced by 5-Aza-CdR and Resveratrol in Breast Cancer Cells
Dr. Weizhu Zhu,
Research Assistant Professor, Department of Surgery, University of North Dakota, USA

15:10-15:25

Coffee Break

15:25-15:45

Title: Letrozole with and without Goserelin in Metastatic Breast Cancer Patients
Dr. Jungsil Ro, Chief, Center for Breast Cancer, National Cancer Center (NCC), Korea

15:45-16:05

Title: The Role of Chemotherapy Sensitivity and Resistance Assays in Gynecologic Oncology
Dr. Pedro F. Escobar, Staff, Section of Gynecologic Oncology, Cleveland Clinic, USA

16:05-16:25

Title: Oncogenic  Function  of  a  Diabetes  Target  SHIP2  Presents  Novel Cancer  Therapeutic  and  Preventive  Opportunities
Dr. Nagendra K. Prasad,
Assistant Professor, Department of Basic Medical Sciences and Purdue Cancer Center, Purdue University, USA

16:25-16:45

Title: Clear Cell Carcinoma of the Ovary – How do You Manage the Distinctive Subtype of Ovarian Cancers?
Dr. Masashi Takano,
Associate Professor, Department of Obstetrics and Gynecology, National Defense Medical College. Japan

16:45-17:05

Title: State of the Art and Controversial Issues in HER2 Assessment
Dr. Caterina Marchio, Research Fellow, Department of Biomedical Sciences and Human Oncology, University of Turin, Italy

17:05-17:25

Title: Transcriptional Role of FOXO1 in Drug Resistance through Antioxidant Defense System in Gynecologic Cancers
Dr. Tomoko Goto, Assistant Professor, Department of Obstetrics and Gynecology, Saitama Medical University, Japan

17:25-17:45

Title: Tumor Incidence in Women Delivered after IVF Treatment
Dr. Per Kristiansson,
Associate Professor, Department of Clinical Medicine, Umea University; Department of Public Health and Research, Sundsvall Hospital, Sweden

Track 2: Basic Research of Oncology
-Scientific Foundation for Innovations

Time and Place

Co-Current Sessions and Activities

June 22, 2009
Monday
13:30-17:00

Track 2-1: Cell Biology in Oncology
-Session Closed, But Poster Opportunity is Still Available. Click here for Poster

Session Chair:

Dr. Zhi-Ren Liu, Professor of Cancer Biology and Georgia Cancer Coalition Distinguished Cancer Scholar, Department of Biology, Georgia State University, Atlanta, Department of Animal Sciences, Auburn University, Auburn, USA
Session Co-Chair:
Dr. Lugang Yu, Senior Lecturer, School of Clinical Science, University of Liverpool, UK

13:30-13:50

Title: Inhibitor-3, A Novel Protein Phosphatase-1 Inhibitor that is Involved in Cell Division and Apoptosis
Dr. Ernest Y.C. Lee, Professor and Chairman, Department of Biochemistry, New York Medical College, USA

13:50-14:10

Title: CTCF Binding to Insulator Sequences between Two Closely Located Genes, RASSF1A and BLU, and Characterization of Their Transcriptional Important CpG Sites in Primary Non-small Cell Lung Cancer
Dr. Yi-Ching Wang,
Distinguished Professor, Department of Pharmacology, College of Medicine, National Cheng Kung University, Taiwan

14:10-14:30

Title: Regulated Hox Gene Expression Reveals a Novel Role for Hox Genes in Myeloid Cell Proliferation and Survival
Dr. Paul Ekert, Associate Professor and Cell Biology Laboratory Group Leader, Children's Cancer Centre, Murdoch Children’s Research Institute, Royal Children's Hospital, Australia

14:30-14:50

Title: The Mechanisms by Which HER2 Promotes Degradation of the Transcriptional Corepressor SMRT: Implication in Tamoxifen-resistant Breast Cancer
Dr. Hung-Ying Kao
, Associate Professor, Department of Biochemistry, School of Medicine, Case Western Reserve University, USA

14:50-15:10

Title: The Circulation of Galactoside-binding Proteins in Cancer Progression
Dr. Lugang Yu, Senior Lecturer, School of Clinical Science, University of Liverpool, UK

15:10-15:25

Coffee Break

15:25-15:45

Title: A Magic Dead Box - for Life and Death
Dr. Zhi-Ren Liu, Professor of Cancer Biology and Georgia Cancer Coalition Distinguished Cancer Scholar, Department of Biology, Georgia State University, Atlanta; Department of Animal Sciences, Auburn University, Auburn, USA

15:45-16:05

Title: Role of Mitogen-activated Protein Kinase Phosphatase-1 (MKP-1) in Drug Resistance
Dr. Gen Sheng Wu,
Associate Professor, Program in Molecular Biology and Genetics, Karmanos Cancer Institute; Department of Pathology, Wayne State University School of Medicine, USA

16:05-16:25

Title: Tautomycetin, A Specific PP1 Inhibitor Suppresses the TNFα/NF-kB Pathway via Inhibition of IKK Activation
Dr. Makoto Ubukata, Professor, Research Faculty of Agriculture, Hokkaido University, Japan

16:25-16:45

Title: Role of REST in Normal Development and Cancer
Dr. Sadhan Majumder,
Professor, Department of Cancer Genetics and Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, USA

16:45-17:05

Title: Prostate Cancer Stem Cells: Biological Pathways Underlying Self-Renewal and Molecular Targeting
Dr. Elaine M Hurt, Staff Scientist, Cancer Stem Cell Section, National Cancer Institute at Frederick, USA

17:05-17:25

Title: IL-6 Promotes a Stem Cell Phenotype in Human Breast Cancer Cells
Dr. Massimiliano Bonafe,
Research Assistant, Department of Experimental Pathology, University of Bologna, Bologna, Italy

June 22, 2009
Monday
13:30-17:00

Track 2-2: Tumor Pathology and Endocrinology in Oncology
-Session Closed, But Poster Opportunity is Still Available. Click here for Poster

Session Chair:
Dr. Wei Xu, Assistant Professor of Oncology, McArdel Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, USA

Session Co-Chair:

Dr. Wancai Yang, Assistant Professor, Department of Pathology, College of Medicine, University of Illinois at Chicago, USA

13:30-13:50

Title: Molecular Targets of Cardiovascular Hormones Anticancer Effects
Dr. David Vesely
, Professor and Chief of Endocrinology, Diabetes and Metabolism, US Department of Veterans Affairs, James A. Halley VA Medical Center, USA

13:50-14:10

Title: The Specific Role and Molecular Mechanism of SRC-1 in Breast Cancer Metastasis
Dr. Jianming Xu
, Associate Professor, Department of Molecular and Cellular Biology, Baylor College of Medicine, USA

14:10-14:30

Title: Switched Pre-mRNA Splicing of Cancer Genes during Stem Cell Differentiation
Dr. Lan Ko
, Assistant Professor, Medical College of Georgia, Institute of Molecular Medicine and Genetics, USA

14:30-14:50

Title: Soy Isoflavone and ER+/ErbB-2+ Breast Cancer
Dr. Xiaohe Yang, Assistant Professor of Pathology, Department of Pathology, University of Oklahoma Health Sciences Center Oklahoma City, USA

14:50-15:10

Title: Estrogen Receptor Beta as a Novel Therapeutic Target in Breast Cancer
Dr. Wei Xu, Assistant Professor of Oncology, McArdel Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, USA

15:10-15:25

Coffee Break

15:25-15:45

Title: Crosstalk between MAPK JNK1/2 and Wnt/β-catenin Signaling in Colorectal Cancer
Dr. Wancai Yang
, Assistant Professor, Department of Pathology, College of Medicine, University of Illinois at Chicago, USA

15:45-16:05

Title: Targeting Early Events of B-cell Receptor Signaling in CLL
Dr. Y. Lynn Wang,
Associate Professor of Pathology and Laboratory Medicine, Associate Attending Pathologist and Director, Molecular Hematopathology Laboratory, Weill Cornell Medical College, New York-Presbyterian Hospital, USA

16:05-16:25
Title: New Development in Estrogen Dependent Cancer - From Endocrinology to Intracrinology
Dr. Hironobu Sasano,
Professor and Chairperson, Department of Pathology, Tohoku University School of Medicine, Japan
16:25-16:45
Title: Ha-ras Oncogene Induces Autophagy and Its Role in Tumorigenesis
Dr. Hsiao-Sheng Liu,
Professor, Departments of Microbiology and Immunology; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Taiwan

16:45-17:05

Title: Coregulators in Resistance to Hormone Therapy
Dr. Hao Zhang
, Professor, Director of Cancer Research Center at Shantou University Medical College, Guangdong, China

17:05-17:30

Title: Coactivators in Breast Cancer Disease Progression: SRC-1 Interactions with HOXC11
Dr. Leonie Young, Senior Lecturer, Department of Surgery, Royal College of Surgeons, Ireland

June 23, 2009
Tuesday
08:30-12:00

Track 2-3: Tumor Immunology and Immunotherapy

Session Chair:

Dr. Shuen-Kuei Liao, Professor of Immunology, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan

Session Co-Chair:

Dr.Matthias Theobald, Professor of Hematology and Director, Department of Hematology, Van Creveld Clinic University Medical Center Utrecht, the Netherlands

08:30-08:50

Title: Second and Third Generation Therapeutic T Cell Receptors
Dr. Matthias Theobald,
Professor of Hematology and Director, Department of Hematology, Van Creveld Clinic, University Medical Center, the Netherlands

08:50-09:10

Title: Mechanism of NFATc1 (Nuclear Factor of Activated T Cells) Regulation of T Cell Function and Bone Homeostasis
Dr. Minggui Pan,
Chief, Division of Oncology/Hematology, Kaier Permanente Medical Center, USA

09:10-09:30

Title: Changes of Cancer Concept: Benefit in Cure due to Inclusion in Treatment, of Immunotherapy and Other Bioregulations
Dr. Claude Boucheix, Chief, Institute of Cancer and Immunogenetics, Oncology Department, Paul-Brousse Hospital, France

09:30-09:50

Title: New Gateways for the Old and Safe Homeopathy
Dr. Dorly de Freitas Buchi, Professor of Cell Biology and Chief, Neoplasic and Inflammatory Cells Laboratory, Cell Biology Department, Federal University of Paraná, Brazil

09:50-10:10

Title: Total HLA Class I Loss in a Renal Cell Carcinoma Cell Line Caused by the Distinct Mutations in the Two Encoding β2 - Microglobulin Genes
Dr. Shuen-Kuei Liao,
Professor of Immunology, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan

10:10-10:25

Coffee Break

10:25-10:45

Title: A Human Tumor Genome Project: From Sequence to Structure, Function and Possibly Drug Targets
Dr. Ge Jin, Assistant Professor, Department of Biological Sciences, Case Western Reserve University, School of Dental Medicine, Case Comprehensive Cancer Center, Cleveland, USA

10:45-11:05

Title: Immunologic Mechanisms of Extracorporeal Photopheresis in Cutaneous T-cell lymphomas Versus Graft Versus Host Disease
Dr. Xiao Ni,
Assistant Professor, Department of Dermatology, The University of TexasMD Anderson Cancer Center, USA

11:05-11:25

Speech Opportunity Available

11:25-11:45

Title: Definition of a Target for Immunotherapy and Results of the First Peptide Vaccination Study in Chronic Lymphocytic Leukemia
Dr. Krzysztof Giannopoulos,
Associate Professor, Clinical Immunology Department, Medical University of Lublin, Poland

11:45-12:05

Title: Control of Anti-tumor CD8+ T Cell Responses
Dr. David J. Morgan, Senior Lecturer in Immunology, Department of Cellular and Molecular Medicine, University of Bristol, UK

12:05-12:30

Panel Discussion
3-5 Topics will be Proposed by Session Chair

June 23, 2009
Tuesday
08:30-12:00

Track 2-4: Hematology-Oncology

Session Chair:

Dr. Gary Guishan Xiao, Associate Professor, Department of Medicine and Department of Medical Mircobiology & Immunology; Director of Genomics & Functional Proteomics Laboratories, Osteoporosis Research Center, Creighton University Medical Center, USA

Session Co-Chair:

Dr. Gerrit Jan Schuurhuis, Head of Stem Cell Laboratory and Manager of Research, Department of Hematology, VU University Medical Center, the Netherlands

08:30-08:50

Speech Opportunity Available

08:50-09:10

Title: ER Stress, Epigenetics and Cancer Therapy: A New Twist on an Old Tale
Dr. Yihong Ye,
Investigator, Laboratory of Molecular Biology, NIDDK, National Institutes of Health, Bethesda, USA

09:10-09:30

Title: The Normal and Leukemic Compartment Can be Discriminated in Acute Myeloid Leukemia
- Consequences for Prognosis and Target Finding

Dr. Gerrit Jan Schuurhuis
, Head of Stem Cell Laboratory and Manager of Research, Department of Hematology, VU University Medical Center, the Netherlands

09:30-09:50

Title: Monitoring of Adenovirus Load in Stool by Real-time PCR Permits Early Detection of Impending Invasive Infection in Patients after Allogeneic Stem Cell Transplantation
Dr. Thomas Lion,
Professor and Medical Director, Labdia Labordiagnostik GmbH, Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Austria

09:50-10:10

Title: Multiple Myeloma: From Genetics to Therapeutics
Dr. Wee Joo Chng, Associate Professor, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore; Consultant Haematologist, Department of Haematology-Oncology, National University Hospital, Singapore

10:10-10:25

Coffee Break

10:25-10:45

Title: MicroRNAs Regulate Estrogen Signaling
Dr.
Gary Guishan Xiao, Associate Professor, Department of Medicine and Department of Medical Mircobiology & Immunology, Director of Genomics & Functional Proteomics Laboratories, Osteoporosis Research Center, Creighton University Medical Center, USA

10:45-11:05

Title: Relevance of Minimal Residual Disease and Chimerism for the Detection of Relapse after Hematopoietic Stem Cell Transplantation
Dr. Bernd Gruhn,
Pediatric Hematologist and Oncologist, Department of Pediatrics, University of Jena, Germany

11:05-11:25

Title: Pharmacogenomic Strategies to Improve Methotrexate Therapy in Childhood Acute Lymphoblastic Leukemia
Dr. Leo Kager,
Associate Professor of Pediatrics, St. Anna Children's Hospital, Austria

11:25-11:45

Title: Small Ribosomal Protein Rpl41 Induces Autophagic Cell Death by Activating DNA-PK
Dr.
Sheng Xiao,
Assistant Professor, Department of Pathology, Harvard Medical School, USA

11:45-12:05

Title: What's New in an Old Technique to Support the Diagnosis and Monitoring of Patients with CLL?
Dr. Rosário Pinto Leite,
Principal Investigator, Centro Hospitalar de Trás-os-Montes e Alto Douro, Genetics Service, Portugal

12:05-12:30

Panel Discussion
3-5 Topics will be Proposed by Session Chair

June 23, 2009
Tuesday
13:30-17:00

Track 2-5: Tumor Virology

Session Chair:
Dr. Jiguo Chen, Assistant Professor, Department of Biological Sciences, Mississippi State University, USA

Session Co-Chair:

Dr. Elena Kashuba, Project Leader, Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Sweden

13:30-13:55

Call for Keynote Speaker

13:55-14:20

Title: Cellular Targets of EBV-encoded Nuclear Antigens (EBNAs) and Their Involvement in Virus-Induced Transformation
Dr. Elena Kashuba, Project Leader, Microbiology and Tumor Biology Center, Karolinska Institute, Sweden

14:20-14:45

Title: Epigenetic Control of Kaposi's Sarcoma-associated Herpesvirus Latency and Reactivation
Dr. Jiguo Chen,
Assistant Professor, Department of Biological Sciences, Mississippi State University, USA

14:45-15:10

Speech Opportunity Available

15:10-15:25

Coffee Break

15:25-15:50

Speech Opportunity Available

15:50-16:15

Title: Human Papillomavirus (HPV) in Tonsillar Cancer: An Epidemic of Virally Induced Carcinoma?
Dr. Linda Marklund, Specialist in ENT, Head and Neck Surgery, Department of Otorhinolaryngology, Head and Neck Surgery, Karolinska University Hospital, Stockholm, Sweden

16:15-16:40
Title: Treatment of Hepatitis B in the Last 10 Years
Dr. Sabina Mahmood, Lecturer, Department of Internal Medicine & Clinical Research, Center for Liver Disease, Kawasaki Medical School Affiliated Kawasaki Hospital, Japan
16:40-17:05
Speech Opportunity Available

17:05-17:30

Panel Discussion
3-5 Topics will be Proposed by Session Chair

June 23, 2009
Tuesday
13:30-17:00

Track 2-6: Tumor Microenvironment and Translational Medicine

Session Chair:
Dr. Debabrata Banerjee, Associate Professor, Department of Medicine and Pharmacology, Cancer Institute of New Jersey, Robert Wood Johnson Medical School, USA

Session Co-Chair:

Dr. Jan H.M. Schellens, Head, Division of Clinical Pharmacology, Department of Medical Oncology, the Netherlands Cancer Institute, The Netherlands

13:30-13:50

Title: Mechanisms of Regulation of Tumor Angiogenesis and the Tumor Cell Differentiation Status by Hypoxia
Dr. Lorenz Poellinger
, Professor of Molecular Biology, Department of Cell and Molecular Biology, Medical Nobel Institute, Karolinska Institutet, Sweden

13:50-14:10

Title: Targeting the Tumor Microenvironment as a Modality to Combat Cancer - Effect of Halofuginone
Dr. Mark Pines
, Director, Institute of Animal Sciences, the Volcani Center, Israel

14:10-14:30

Title: Modeling Tumor Stroma Interaction
Dr. Debabrata Banerjee,
Associate Professor, Department of Medicine and Pharmacology, Cancer Institute of New Jersey, Robert Wood Johnson Medical School, USA

14:30-14:50

Title: Novel Therapeutic Targets in Thoracic Oncology
Dr. Michael J Lind,
Professor and Head - Department of Oncology, Castle Hill Hospital, UK

14:50-15:10

Title: Significance of Plasma Fibronectin in Radiotherapy
Dr. Roxana Baluna, Associate Professor, Department of Radiology, Louisiana State University Health Science Center, and Feist-Weiller Cancer Center, USA

15:10-15:25

Coffee Break

15:25-15:45

Title: Phase 0 Studies in Anticancer Drug Development
Dr. Serena  Marchetti,
Professor, Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, The Netherlands & Dutch Medicines Evaluation Board (CBG-MEB), The Netherlands

15:45-16:05

Title: Crossing The Barrier: From Intravenous to Effective Oral Formulations of Chemotherapy
Dr. Jan H.M. Schellens
,
Head, Division of Clinical Pharmacology, Department of Medical Oncology, the Netherlands Cancer Institute, The Netherlands

16:05-16:25
Title: Pharmacologic Ascorbate as a Pro-oxidant: An Unanticipated Role in Cancer Treatment
Dr. Qi Chen, Assistant Professor, Department of Pharmacology, The University of Kansas Medical Center, USA
16:25-16:45

Speech Opportunity Available

16:45-17:05
Speech Opportunity Available

17:05-17:30

Panel Discussion
3-5 Topics will be Proposed by Session Chair

June 24, 2009
Wednesday
08:30-12:00

Track 2-7: Cancer/Tumor Invasion and Metastasis and Drug Discovery

Session Chair:
Dr. Zhimin Lu, Assistant Professor, Department of Neuro-Oncology, The University of Texas, MD Anderson Cancer Center, USA

Session Co-Chair:

Dr. Jian Cao, Associate Professor of Medicine and Pathology, Graduate Programs in Molecular & Cellular Biology, Molecular & Cellular Pharmacology, Stony Brook University, USA

08:30-08:50

Keynote Speech:
Title:
Development of Selective, Exosite Binding Matrix Metalloproteinase (MMP) Inhibitors
Dr. Gregg B. Fields, Professor, Department of Biochemistry, University of Texas Health Science Center, San Antonio, USA

08:50-09:10

Title: The Role of the Cyclooxygenase-2 Pathway in Cancer Metastasis
Dr. Amy M Fulton, Professor, University of Maryland Marlene and Stewart Greenbaum Cancer Center, USA

09:10-09:30

Title: The Androgen Signaling in Prostate Tumorigenesis and Prostate Cancer Progression
Dr. Zhengxin Wang, Associate Professor, Principal Investigator/Program Director, Department of Cancer Biology, MD Anderson Cancer Center, USA

09:30-09:50

Title: Cross-talk between EGFR and Wnt Pathways Promotes Tumor Cell Invasion
Dr. Zhimin Lu, Assistant Professor, Department of Neuro-Oncology, The University of Texas, MD Anderson Cancer Center, USA

09:50-10:10

Title: The Roles of Natural Killer - Cell Immunoglobulin Receptors (KIR) in Immune Escape and Cancer Metastasis
Dr. Daniel C. Chan, Professor of Medicine, Division of Medical Oncology, University of Colorado Denver, USA

10:10-10:25

Coffee Break

10:25-10:45

Title: Collagen Remodelling by Osteoblast and Prostate Cancer Cell Interactions in Metastatic Bone Lesions
Dr.
Justin Sturge,
Metastasis Team Leader & Lecturer, Division of Surgery, Oncology, Reproductive Biology and Anaesthetics Imperial College London, UK

10:45-11:05

Title: aPKC and Apical-basal Polarity Signaling in Embryonic CNS Development and Glioblastoma
Dr. Sourav Ghosh
, Full Investigator, Arizona Cancer Center; Adjunct Associate Investigator, Cancer and Cell Biology Division, Translational Genomics Research Institute; Assistant Professor, Department of Basic Medical Sciences, USA

11:05-11:25

Title: Epithelial Mesenchymal Transition In Early Dissemination Of Breast Carcinoma Cells
Dr. Jean Paul Thiery,
Professor and Principal Investigator, Institute of Molecular Cell biology (IMCB), A*STAR, Singapore

11:25-11:45
Title: MT1-MMP in Cancer Invasion and Metastasis: Migration toward Treatment and Prevention
Dr. Jian Cao, Associate Professor of Medicine and Pathology, Graduate Programs in Molecular & Cellular Biology, Molecular & Cellular Pharmacology, Stony Brook University, USA
11:45-12:05
Title: The Activation of AKT Signaling as the Result of the Loss of Androgen Sensitivity in Prostate Cancer
Dr. Piotr Laidler, Professor of Biochemitry, Jagiellonian University Medical College, Poland
12:05-12:25
Speech Opportunity Available

June 24, 2009
Wednesday
08:30-12:00

Track 2-8: Tumor Genetics and Omics Research
-Session Closed, But Poster Opportunity is Still Available. Click here for Poster
Session Chair:
Dr. David S. Schrump, Surgery Branch Clinical Head and Senior Investigator, Thoracic Oncology Section, National Cancer Institute, USA
Co-Chair:
Dr. Zhong Chen, Staff Scientist, Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Other Communication Disorders, USA

08:30-08:50

Title: Tumor Lymphangiogenesis and Cancer Metastasis: Transcriptional Profiling of Tumor Stroma
Dr. Michael Detmar, Professor of Pharmacogenomics and Chair, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, Switzerland

08:50-09:10

Title: A Novel DNA Damage Response that Involves the Alteration of the of Human DNA Polymerase δ
Dr. Marietta Y.W.T. Lee,
Professor, Department of Biochemistry and Molecular Biology, New York Medical College, USA

09:10-09:30

Title: Epigenetic Alterations and Gene Expression Profiles in Respiratory Epithelia Mediated by Cigarette Smoke
Dr. David S. Schrump, Surgery Branch Clinical Head and Senior Investigator, Thoracic Oncology Section, National Cancer Institute, USA

09:30-09:50

Title: Acquisition of Stem Cell Traits in Aggressive Tumors: Implications in Prognosis and Therapy
Dr. Hsei-Wei Wang, Associate Professor, Institute of Microbiology and Immunology, VGH-YM Genome Research Center, National Yang-Ming University, Taiwan

09:50-10:10

Title: Proteomics as a Tool for Biomarker Development in Early Clinical Trials
Dr. Heinz Zwierzina, Professor, Department of Internal Medicine/Medical Oncology, Innsbruck Medical University; Chairman, Biotherapy Development Association (BDA), Austria

10:10-10:25

Coffee Break

10:25-10:45

Title: Molecular Signatures of Signal Pathways and Transcriptional Controls in Heterogeneous Head and Neck Cancer Subsets Related to Tp53 Status
Dr. Zhong Chen
, Staff Scientist, Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Other Communication Disorders, USA

10:45-11:05

Title: Mechanisms Underlying Chromosomal Instability in Tumorigenesis Induced by Cell-fusion Mediated by Viruses
Dr. Yuesheng Jin,
Department of Clinical Genetics, Lund University Hospital, Sweden

11:05-11:25

Title: Gene Fusion Discovery in Prostate Cancer by Next Generation Sequencing
Dr. Xuhong Cao,
Lab Manager of Dr. Arul Chinnaiyan Lab, Howard Hughes Medical Institute, Michigan Center for Transnational Pathology, University of Michigan, USA

11:25-11:45

Title: P53 IHC Protein Expression and Tumor Size Predict Survival Benefit from Adjuvant Chemotherapy in Stage IB Non Small Cell Lung Cancer Patients
Dr. Keyue Ding,
Assistant Professor and Senior Biostatistician, National Cancer Institute of Canada, Clinical Trials Group, Department of Community Health & Epidemiology, Queen's University, Canada

11:45-12:05

Title: The P53 Pathway in Cancer: Potential Therapeutic Applications
Dr. Roger Leng
, Assistant Professor and AHFMR Scholar, 370A Heritage Medical Research Centre, Department of Laboratory Medicine & Pathology, University of Alberta, Canada

12:05-12:25

Title: Prognostic Significance of Genetic Testing Methods in MDS & Leukemias
Dr. Zamecnikova Adriana, Supervisor, Laboratory of Cancer Genetics, Department of Hematology, Kuwait Cancer Control Center, Kuwait

June 24, 2009
Wednesday
13:30-17:00

Track 2-9: Cancer Prevention, Epidemiology and Cancer Surveillance

Session Chair:
Dr. Thomas D. Szucs, Professor, Institute of Social -and Preventive Medicine, University of Zurich, Zurich, Switzerland

Session Co-Chair:

Dr. David J Waters, Professor and Associate Director, Center on Aging and the Life Course, Purdue University, USA

13:30-13:50

Keynote Speech:
Title: Cancer Epidemiology: Role of Diet
Dr. Patricia Tai, Professor, Department of Radiation Oncology, Allan Blair Cancer Centre and University of Saskatchewan, Canada

13:50-14:10

Title: Cancer and Broadcasting Radiation: Facts from Radio Engineering and Cancer Epidemiology
Mr. Örjan Hallberg,
Founder, Hallberg Independent Research, Sweden

14:10-14:30

Title: Carotenoids and Cancer Prevention
Dr. Xiang-Dong Wang, Director Senior Scientist and Professor of Nutrition and Medicine, Nutrition and Cancer Biology Lab, JM Human Nutrition Research Center, USA

14:30-14:50

Speech Opportunity Available

14:50-15:10

Title: More is not Necessarily Better: Preventing Cancer in a U-Shaped World
Dr. David J Waters, Professor and Associate Director, Center on Aging and the Life Course, Purdue University, USA

15:10-15:25

Coffee Break

15:25-15:45

Title: At What Cost Innovation? - Establishing the Value of New Cancer Therapeutics
Dr. Thomas D. Szucs, Professor, Institute of Social and Preventive Medicine, University of Zurich, Switzerland

15:45-16:05

Title: Smoking Cessation for Cancer Patients: An Opportunity to Increase the Reach of Effective Smoking Cessation Programs
Dr.  Lori A. Bastian
, Associate Professor, Department of Medicine, Division of General Medicine, Duke University Comprehensive Cancer Center, USA

16:05-16:25
Title: High Risk Lesions Identified in Breast Cancer Screening: Individualized Management
Dr. Lei Huo,
Assistant Professor, Department of Pathology, University of Texas M. D. Anderson Cancer Center, USA
16:25-16:45
Title: Association of  Gamma - Glutamyltransferase and Risk of Cancer Incidence in Men: A Prospective Study
Dr. Alexander M Strasak, Assistant Professor, Department of Medical Statistics, Informatics and Health Economics, Innsbruck Medical University, Austria
16:45-17:05

Title: Finding the Optimal Selenium Status for Cancer Risk Reduction
Dr. Emily Chiang
, Research Scientist, Departments of 1 Veterinary Clinical Sciences, Gerald P. Murphy Cancer Foundation, USA

17:05-17:25

Title: Association of Gene Polymorphisms with Colorectal Cancer in Relation to Smoking
Dr. Kayo Osawa, Faculty of Health Sciences, Kobe University Graduate School of Health Sciences, Kobe, Japan

17:25-17:45

Title: Can Saline be an Alternative to Aesthetic Surgery in Extended Breast Quadrantectomy?
Dr. Maha Abdelhadi, Professor and Head of the Breast Unit, Department of Surgery, King Fahd Hospital of the University, Saudi Arabia

June 25, 2009
Thursday
08:30-12:00

Track 2-10: Molecular Oncology
-Session Closed, But Poster Opportunity is Still Available. Click here for Poster

Session Chair:

Dr. Antonio Gómez Muñoz, Professor, Department of Biochemistry and Molecular Biology, University of the Basque Country, Spain

Session Co-Chair:

Dr. Zhongjian Xie, Research Scientist and Principal Investigator, Endocrine Unit, VA Medical Center, San Francisco, USA

08:30-08:50

Keynote Speech:
Title:Signal Integration by P38 Map Kinases in Tumorigenesis
Dr. Angel R. Nebreda, Professor in Medical Genetics, Spanish National Cancer Center(CNIO), Spain

08:50-09:10

Title: Smurf2 Promotes Metastasis of Breast Cancer Cells by Enhancing Migration and Invasiveness
Dr. Ying E. Zhang
, Senior Investigator, Laboratory of Cellular & Molecular Biology,National Cancer Institute, NIH, USA

09:10-09:30

Title: Ceramide 1-phosphate (C1P): A Novel Regulator of Cell Growth and Death. Discovery of a Specific C1P Receptor that Mediates Cell Migration
Dr. Antonio Gómez Muñoz, Professor, Department of Biochemistry and Molecular Biology, University of the Basque Country, Spain

09:30-09:50

Title: Role of PKC-isoforms in the Regulation of the Tumor Suppressor PDCD4 in Human Hepatocellular Carcinoma Cells
Dr. Sachiko Matsuhashi
, Professor, Department of Internal Medicine, Saga Medical School, Saga University, Japan

09:50-10:10

Title: Nodal Signaling in Ovarian Cancer Cells: Functions, Target Genes and Modulation by MicroRNA
Dr. Chun Peng, Professor, Department of Biology, York University, Canada

10:10-10:20

Coffee Break

10:20-10:40

Title: PLC-gamma1 and PIKE in Squamous Cell Carcinoma Cells
Dr. Zhongjian Xie
, Research Scientist and Principal Investigator, Endocrine Unit, VA Medical Center, USA

10:40-11:00

Title: The Mechanism by Which Tumor Suppressor Pdcd4 Inhibits Tumorigenesis
Dr. Hsin-Sheng Yang,
Assistant Professor, Graduate Center for Toxicology, University of Kentucky, USA

11:00-11:20

Title: ErbB3 as a Novel Target of HDAC Inhibitor against ErbB2-overexpressing Breast Cancers
Dr. Bolin Liu,
Assistant Professor, Department of Pathology, University of Colorado at Denver and Health Sciences Center, USA

11:20-11:40

Title: Genomic Amplification and Oncogenic Properties of Histone Demethylase Gene in Breast Cancer
Dr.
Zeng-Quan Yang, Assistant Professor, Karmanos Cancer Institute, Wayne State University, USA

11:40-12:00

Title: RPA2 Phosphorylation Inhibits RPA2 Ubiquitylation and Promotes Homologous Recombination
Dr. Junran Zhang
, Assistant Professor, Department of Radiation Oncology, Washington University School of Medicine, USA

12:00-12:20

Title: Apoptosis Repressor with Caspase Recruitment Domain Contributes to Chemotherapy Resistance by Abolishing Mitochondrial Fission Mediated by Dynamin-related Protein-1
Dr. Li Pei-Feng,
Professor, Division of Cardiovascular Research, National Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Zoology, Chinese Academy of Sciences, China

12:20-12:40

Title: Oncogene-induced Oxidative Stress: Implications for Cancer Progression and Drug Resistance in Leukemia
Dr. Joya Chandra,
Associate Professor of Pediatrics Research, Children's Cancer Hospital at M.D. Anderson, University of Texas M.D. Anderson Cancer Center, USA

Track 3: Anti-Cancer Drug Discovery and Therapeutics
-From the Bench to the Bedside

Time and Place

Co-Current Sessions and Activities

June 22, 2009
Monday
13:30-17:00

Track 3-1: Transcription Factors, Kinase as Drug Targets in Cancer

Session Chair:
Dr. Henry Yu, Senior Principal Investigator, EMD-Serono Research Institute, USA

Session Co-Chair:

Dr. Nianli Sang, Associate Professor, Department of Biology, Drexel University, USA

13:30-13:50

Keynote Speech:
Title:
Exploring the Biological Space of FOXO Transcription Factors: Discovery of Kinase Inhibitors for Anticancer Therapy
Dr.
Wolfgang Link,
Experimental Therapeutics Program, Centro Nacional de Investigaciones Oncologicas (CNIO), Spain

13:50-14:10

Title: New Orally Available PI3K Inhibitors
Dr. Juergen Engel, Executive VP & CSO, Eterna Zentaris GmbH, Germany

14:10-14:30

Title: Dbait: A New Strategy to Improve Radiotherapy by Fooling Tumour Cell Repair System
Dr. Marie Dutreix,
Director of Research of the Centre of National Research in Science (CNRS); Co-founder, DNA Therapeutics SA, France

14:30-14:50

Title: Discovery and Pre-clinical Evaluation of a Novel Allosteric MEK Inhibitor as Anti-cancer Agent
Dr. Henry Yu, Senior Principal Investigator, EMD-Serono Research Institute, USA

14:50-15:10

Title: Loss of Tumor Suppressor RUNX3 in Gastric Cancer Cells Elevates Akt/β-catenin/cyclin D1 Signaling and Promotes Tumorigenesis
Dr. Pei- Jung Frank Lu,
Associate Professor, Institute of Clinical Medicine; School of Medicine, National Cheng- Kung University, Taiwan

15:10-15:25

Coffee Break

15:25-15:45

Title: Hypoxia-inducible Factors: Targets for Cancer Therapy
Dr. Nianli Sang, Associate Professor, Department of Biology, Drexel University, USA

15:45-16:05

Title: Growth Factor Signal Transduction Proteins as Potential Markers of Antitumor Drug Resistance and Targets for Its Prevention
Dr. Elena Gershtein, Professor, Laboratory of Clinical Biochemistry, Russian N.N. Blokhin Cancer Research Center RAMS, Russia

16:05-16:25
Title: Targeting Class IA PI3K in Cancer: From PI3K to the Kinome and the Next Frontier
Dr. Jean J. Zhao, Assistant Professor, Dana-Farber Cancer Institute, Department of Cancer Biology, Harvard Medical School, USA
16:25-16:45
Title: From Integrated Microarray Analyses to Novel Metastasis Associated Gene Identification
Dr. Jin-Mei Lai,
Assistant Professor, Department of Life Science, Fu-Jen Catholic University, Taiwan

16:45-17:05

Title: Molecular Stratification of NSCLC for Treatment with Tyrosine Kinase Inhibitors
Dr. Sam Murray, Director, Department of Molecular Biology and Genetics, Metropolitan Hospital, Greece

17:05-17:30

Speech Opportunity Available

June 22, 2009
Monday
13:30-17:00

Track 3-2: The Immune System, Inflammation, and Cancer

Session Chair:
Dr. Seung J Baek, Associate Professor, Department of Pathobiology, College of Veterinary Medicine, The University of Tennessee, USA

Session Co-Chair:

Dr. Min Xu, Senior Scientist, Department of Surgery, Harrison Department of Research, University of Pennsylvania, USA

13:30-13:50

Keynote Speech:
Title: TRAIL Receptor Signaling and Therapeutics
Dr. Wafik S. El-Deiry, Professor of Medicine, Genetics, and Pharmacology; Co-Program Leader, Radiation Biology & Imaging Program, Abramson Comprehensive Cancer Center; Associate Director for Physician-Scientist Training, Hematology-Oncology Division, University of Pennsylvania School of Medicine, USA

13:50-14:10

Title: Proapoptotic Protein NAG-1 Suppresses Inflammation
Dr. Seung J Baek, Associate Professor, Department of Pathobiology, College of Veterinary Medicine, The University of Tennessee, USA

14:10-14:30

Title: Interactions of TLR Agonist Activated DCs with Tumor Stromal-derived Molecules
Dr. Min Xu,
Senior Scientist, Department of Surgery, Harrison Department of Research, University of Pennsylvania, USA

14:30-14:50

Speech Opportunity Available

14:50-15:10

Speech Opportunity Available

15:10-15:25

Coffee Break

15:25-15:45

Title: Role of IRF8 in Apoptosis and Metastasis in Non-hematopoietic Cancer
Dr. Kebin Liu, Assistant Professor, Department of Biochemistry and Molecular Biology, Medical College of Georgia, USA

15:45-16:05

Title: Inflammatory Chemokines in Malignancy: Regulation by Genetic Components and Host Factors
Dr. Adit Ben-Baruch, Head, Cancer Biology Research Center, Dept. Cell Research and Immunology, Tel Aviv University, Israel

16:05-16:25

Title: Innate Immunity and Hematological Malignancies, Describing the Role of Toll-like Receptors
Dr.
Charalambos Kartsios,
Consultant Haematologist, Laboratory of Flow Cytometry, Lymphoma Clinic Haematology Department, Papageorgiou General Hospital, Thessaloniki, Greece

16:25-16:45
Title: Serum Amyloid A: From Inflammation to Cancer and Possibly Tumor Marker and Therapeutic Target
Dr. Simcha Urieli-Shoval,
Head, Hematology Unit Research Laboratory, Hadassah-Hebrew University Medical Center, Mount Scopus, Jerusalem, Israel

16:45-17:05

Speech Opportunity Available

17:05-17:30

Panel Discussion
3-5 Topics will be Proposed by Session Chair

June 23, 2009
Tuesday
08:30-12:00

Track 3-3: Novel Molecular Target to Cancer
-Session Closed, But Poster Opportunity is Still Available. Click here for Poster

Session Chair:
Dr. James S Norris, Professor and Chairman, Department of Molecular Biology and Immunology Microbiology & Immunology Medical University of South Carolina, USA

Session Co-Chair:

Dr. Shi-Yong Sun, Associate Professor and GCC Distinguished Cancer Research Scholar, Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, USA

08:30-08:50

Title: Calcium and Cancer: Targeting Ca2+ Transport
Dr. Sarah Roberts-Thomson,
Professor, Reader & Postgraduate Coordinator, School of Pharmacy, The University of Queensland, Australia

08:50-09:10

Title: Targets in Cancer Associated with Sphingolipid Metabolism in Prostate Cancer
Dr. James S Norris
, Professor and Chairman, Department of Molecular Biology and Immunology, Microbiology & Immunology Medical University of South Carolina, USA

09:10-09:30

Title: NGEP, A Potential Target for Prostate Cancer Immunotherapy, Identified by EST Database Mining
Dr. Tapan K. Bera, Associate Scientist, Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA

09:30-09:50

Title: In Vitro and in Vivo Study of Phloretin-induced Apoptosis in Human Liver Cancer Cells through Inhibition of Type ll Glucose Transporter
Dr. Yuan-Soon Ho,
Professor, School of Medical Laboratory Science and Biotechnology, College of Medicine, Taipei Medical University, Taiwan

09:50-10:10

Title: Enhancing mTOR-targeted Cancer Therapy
Dr. Shi-Yong Sun, Associate Professor and GCC Distinguished Cancer Research Scholar, Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, USA

10:10-10:25

Coffee Break

10:25-10:45

Title: Regulation of XIAP Translation and Induction by MDM2 Following Irradiation
Dr. Muxiang Zhou, Associate Professor, Division of Pediatric Hematology/Oncology/BMT, Emory University School of Medicine, USA

10:45-11:05

Title: Human Monoclonal Antibodies Targeting the IGF System for Cancer Treatment
Dr. Yang Feng, Center of Cancer Research Nanobiology Program, National Cancer Institute, USA

11:05-11:25

Title: Evaluation of Insulin Receptor Substrate-4 (LRS-4) as Therapeutic Target in Heptocarcinoma
Dr. Luis G. Guijarro,
Professor of Biochemistry, Department of Biochemistry and Molecular Biology, Alcala University, Spain

11:25-11:45

Title: E3 Ubiquitin Ligases as Novel Molecular Targets in Breast Cancer
Dr. Ceshi Chen,
Assistant Professor, The Center for Cell Biology and Cancer Research, Albany Medical College, USA

11:45-12:05

Title: Targets for Therapy in Head and Neck Cancer
Dr. Xiang Liu, Assistant Professor, Department of Microbiology and Immunology, Medical University of South Carolina, USA

12:05-12:25

Title: VEGFA Upregulates FLJ10540 and Modulates Migration and Invasion of Lung Cancer via PI3K/AKT Pathway
Dr. Chi-Ying Huang,
Professor, Institute of Clinical Medicine, National Yang-Ming University, Taiwan

June 23, 2009
Tuesday
08:30-12:00

Track 3-4: Vascular Targeting and Targeting Angiogenesis

Session Chair:

Dr. Paolo Mignatti, Professor of Medicine, New York University School of Medicine, Depts. of Cardiothoracic Surgery and Cell Biology, Sackler School of Graduate Biomedical Studies, NYU Cancer Institute, New York, USA

Session Co-Chair:

Dr. Weibo Cai, Assistant Professor, Departments of Radiology & Medical Physics, School of Medicine & Public Health, University of Wisconsin – Madison, USA

08:30-08:50

Keynote Speech:
Title: Novel, Unexpected Mechanisms of Tumor Progression and Angiogenesis
Dr. Paolo Mignatti, Professor of Medicine, New York University School of Medicine, Depts. of Cardiothoracic Surgery and Cell Biology, Sackler School of Graduate Biomedical Studies, NYU Cancer Institute, New York, USA

08:50-09:10

Title: Basal/Squamous Cell Cancer Associated Fibroblasts: Factor of Tumor Progression
Dr. Karel Smetana, Professor, Charles University 1st Faculty of Medicine Institute of Anatomy and Center of Cell Therapy and Tissue Repair, Czech Republic

09:10-09:30

Title: Novel Kinase Inhibitors for Cancer Treatment
Dr. Weiguo Su,
Senior Vice President, Hutchison MediPharma Ltd., China

09:30-09:50

Title: PI3K/p70S6K1 Signaling in Angiogenesis and Tumorigenesis
Dr. Bing-Hua Jiang, Professor, Department of Pathology, Nanjing Medical University, China

09:50-10:10

Title: aP2-Cre-mediated Expression Activation of Oncogenic PLAG1 Results in Blood Vessel Malformations and Hemangiomas in Mice
Dr.
A.J.M. Vermorken,
Professor of Molecular Oncology, University of Leuven, Belgium

10:10-10:25

Coffee Break

10:25-10:45

Title: VEGF Production and Tumour Size Depends on Selenium Status in Hepatocellular Carcinoma
Dr. Nataliya Rohr-Udilova, Head of Basic Research Unit, Department of Gastroenterology and Hepatology, Medical University of Vienna, Austria

10:45-11:05

Title: Multimodality Molecular Imaging and Therapy Targeting Tumor Angiogenesis: Peptides, Proteins, and Nanopartic
Dr. Weibo Cai,
Assistant Professor, Departments of Radiology & Medical Physics, School of Medicine & Public Health, University of Wisconsin – Madison, USA

11:05-11:25

Title: Angiogenesis and Soluble Receptors
Dr.
Taner Ozgurtas,
Associate Professor, Department of Biochemistry, Gulhane Military Medical School, Ankara, Turkey

11:25-11:45

Title: Angiopoietins in Lung Cancer
Dr.
Kwang Joo Park,
Associate Professor, Lung Cancer Center, Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine, South Korea

11:45-12:05

Speech Opportunity Available

12:05-12:30

Panel Discussion
3-5 Topics will be Proposed by Session Chair

June 23, 2009
Tuesday
13:30-17:00

Track 3-5: Rational Drug Design vs High Throughput Cancer Drug Screening
-Session Closed, But Poster Opportunity is Still Available. Click here for Poster

Session Chair:
Dr. Xuedong Liu, Associate Professor, Department of Chemistry and Biochemistry, University of Colorado-Boulder, USA

Session Co-Chair:

Dr. Hubert Yin, Assistant Professor, Department of Chemistry and Biochemistry, University of Colorado-Boulder, USA

13:30-13:50

Keynote Speech:
Title: Steroid Sulfatase Inhibitors & the Aryl Sulfamate Pharmacophore: From Concept to Clinic
Dr. Barry Potter,
Professor and Head of Medicinal Chemistry, Department of Pharmacy & Pharmacology, University of Bath, Claverton Down, UK

13:50-14:10

Title: High Through Screening of Small Molecule Inhibitors that Prevents Excessive Proteolysis of Tumor Suppressor p27Kip1
Dr. Xuedong Liu,
Associate Professor, Department of Chemistry and Biochemistry, University of Colorado-Boulder, USA

14:10-14:30

Title: SB939, A Potent and Orally-active HDAC Inhibitor
Dr. Eric T Sun,
Senior Scientific Advisor, S*BIO Pte Ltd., Singapore

14:30-14:50

Title: New Technologies for RNAi Screening with Pooled Lentiviral shRNA Libraries
Dr. Debbie Deng, Research Scientist, Cellecta, Inc., Mountain View, CA, USA

14:50-15:10

Title: Zoledronic Acid Exerts Anti-cancer Activity and Geranylgeranylation Could be a Novel Molecular Target of the Treatment of Prostate Cancer
Dr. Naohiro Fujimoto, Professor, Department of Urology, University of Occupational and Environmental Health, Japan

15:10-15:25

Coffee Break

15:25-15:45

Title: Novel Inhibitors as Potential Drug Candidates for Cancer-related Chronic Pain
Dr. Hubert Yin, Assistant Professor, Department of Chemistry and Biochemistry, University of Colorado-Boulder, USA

15:45-16:05

Title: A New Polymer-based Nanoformulation for Overcoming Multi-drug Resistance in Cancer
Dr. Elena V. Batrakova, Assistant Professor, Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, USA

16:05-16:25

Title: Design and Synthesis of Anti-cancer Proteasome Inhibitors
Dr. Li Huang, Research Scientist of Surgical Science, Surgery Department Duke University Medical Center, USA

16:25-16:45
Title: Identification of Statins as Novel HDAC Inhibitors: Homology Modeling, Docking, and Experimental Verification
Dr. Jung-Hsin Lin, Assistant Research Fellow, Division of Mechanics, Research Center for Applied Sciences & Institute of Biomedical Sciences, Academia Sinica; Assistant Professor, School of Pharmacy, National Taiwan University, Taiwan
16:45-17:05

Title: Tumor Optical Imaging: Its Implications for Discovery of Novel Anticancer Agents
Dr. Yunpeng Ye, Research Instructor in Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, USA

17:05-17:30

Speech Opportunity Available

June 23, 2009
Tuesday
13:30-17:00

Track 3-6: Validated Animal Models in Anticancer Drug Development

Session Chair:
Dr. Robert Sigler, President, Vet Pathology and IND Services, USA

Session Co-Chair:

Dr. Amr Amin, Associate Professor, Cell and Molecular Biology, Biology Department, UAE University, United Arab Emirates

13:30-13:50

Call for Keynote Speaker

13:50-14:10

Speech Opportunity Available

14:10-14:30

Title: Preclinical Efficacy Models Used to Assess Anticancer Compounds: Dissecting the Mechanism of Action 
Dr. Robert Sigler, President, Vet Pathology and IND Services, USA

14:30-14:50

Title: Reduction of DNA-damaging Effect of Different Genotoxins by Natural Lignin-based Preparations
Dr. Bozena Kosikova, Professor, Institute of Chemistry, Slovak Academy of Sciences, Slovak Republic

14:50-15:10

Title: LMP2-deficient Mice as Animal Model of Spontaneous Uterine Leiomyosarcoma for Development of Diagnosis and Anti-tumor Drug
Dr. Takuma Hayashi, Associate Professor, Department of Immunology and Infectious Disease, Shinshu University Medical School, Japan

15:10-15:25

Coffee Break

15:25-15:45

Title: Insights into Chemotherapy-induced Neurotoxicity from Animal Studies
Dr. Mark J. McKeage, Associate Professor, Department of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medicine and Health Science, University of Auckland, New Zealand

15:45-16:05

Title: PLAG1 Oncogene-Induced Tumors: Versatility in Tumorigenesis and Generation of Various Tumor Mouse Models
Dr. Wim J.M. Van de Ven
, Professor, Laboratory for Molecular Oncology, Department of Human Genetics, University of Leuven, Belgium

16:05-16:25
Speech Opportunity Available
16:25-16:45

Speech Opportunity Available

16:45-17:05

Title: Green Algae Protect against Drug-induced Breast Cancer in Mammals
Dr. Amr Amin, Associate Professor, Cell and Molecular Biology, Biology Department, UAE University, United Arab Emirates

17:05-17:30

Panel Discussion
3-5 Topics will be Proposed by Session Chair

June 24, 2009
Wednesday
08:30-12:00

Track 3-7: Analytical Techniques and Novel Drug Delivery System for Anti-cancer Drugs

Session Chair:

Dr. Johnson Liu, Research Fellow/Senior Scientist, Department of Pharmacology & Clinical Pharmacology, School of Medical Sciences, Faculty of Medical & Health Sciences, University of Auckland, New Zealand

Session Co-Chair:

Dr. Volkmar Weissig, Associate Professor of Pharmacology; Department of Pharmaceutical Sciences, Midwestern University College of Pharmacy Glendale; Associate Editor, Journal of Liposome Research, USA

08:30-08:55

Title: Mitochondria-targeted Delivery of Pro-apoptotic Drugs Using Mitochondria-specific Pharmaceutical Nano Carrier Systems
Dr. Volkmar Weissig, Associate Professor of Pharmacology; Department of Pharmaceutical Sciences, Midwestern University College of Pharmacy Glendale; Associate Editor, Journal of Liposome Research, USA

08:55-09:20

Title: TBD
Dr. Haihong Ni,
Director of Computational Science, Chemizon Inc, USA

09:20-09:45

Title: Nanotechnology in Cancer Treatment
Dr. Manfred George Krukemeyer, Professor, Department of Surgical Research, University of Muenster, Medical School, Germany

09:45-10:10

Title: The Development of Bioanalytical Methods of Anticancer Drugs for Clinical Samples Using HPLC, ICP-MS and LC-MS Related Techniques
Dr. Johnson Liu, Research Fellow/Senior Scientist, Department of Pharmacology & Clinical Pharmacology, School of Medical Sciences, Faculty of Medical & Health Sciences, University of Auckland, New Zealand

10:10-10:25

Coffee Break

10:25-10:50

Title: The Advantages of a Novel in-vivo like Drug Discovery Method Using Primary Tumor Cells
Dr. Henriette Skribek, Researcher, Department of Tumor, Cell and Microbiology, Karolinska Institute, Sweden

10:50-11:15

Title: Calibration of Pure Lipid Nanopores Appeared in the BLM at the Lipid Phase Transition
Dr. Valery Antonov,
Professor, Moscow Sechenov Medical Academy, Russia

11:15-11:40

Title: Anticancer Polymer-linker-drug Conjugates
Dr. Ying Chau, Assistant Professor, Department of Chemical Engineering, Hong Kong University of Science and Technology, China

11:40-12:05

Speech Opportunity Available

12:05-12:30

Speech Opportunity Available

June 24, 2009
Wednesday
08:30-12:00

Track 3-8: Targeted Cancer Therapy

Session Chair:

Dr. Ting-Chao Chou, Director, Preclinical Pharmacology Core Laboratory, Molecular Pharmacology & Chemistry Program, Memorial Sloan-Kettering Cancer Center, USA

Session Co-Chair:

Dr. Lily Yang, Associate Professor of Surgery and Radiology, Nancy Panoz Endowed Chair of Surgery in Cancer Research, Winship Cancer Institute, Emory University School of Medicine, USA

08:30-08:50

Title: Therapeutic Cure of Xenograft Tumors by the Microtubule Targeting Epothilone, Iso-oxazole-fludelone, and Its Superior Efficacy over Taxol
Dr. Ting-Chao Chou, Director, Preclinical Pharmacology Core Laboratory, Molecular Pharmacology & Chemistry Program, Memorial Sloan-Kettering Cancer Center, USA

08:50-09:10

Title: Cell-based HTS to Evaluate Cancer Drugs
Dr. Michelle Xia, Vice president of In vitro/Cell Biology, Crown Bioscience, China

09:10-09:30

Title: Peptide-targeted Chemotherapy and Diagnosis
Dr. Chin-Tarng Lin, Professor Department of Pathology, National Taiwan University Hospital, Taiwan

09:30-09:50

Title: Integrin-targeted Cancer Therapy
Dr. Michael Agrez, Chairman and Director, INTER-K Pty Ltd; Associate Professor, School of Medicine and Public Health, University of Newcastle, Australia

09:50-10:10

Title: The Cell Fate Determination Factor DACH1 Attenuates Breast Cancer Stem Cell Self-renewal and Propagation
Dr. Kongming Wu,
Assistant Professor, Departments of Cancer Biology and Medical Oncology, Thomas Jefferson University, USA

10:10-10:25

Coffee Break

10:25-10:45

Title: Multifunctional Nanoparticles for Targeted Tumor Imaging and Therapy
Dr. Lily Yang, Associate Professor of Surgery and Radiology, Nancy Panoz Endowed Chair of Surgery in Cancer Research, Winship Cancer Institute, Emory University School of Medicine, USA

10:45-11:05

Title: EGFR- and Downstream Mutations in Salivary Gland Carcinomas
Dr. Regine Dahse, Head and Professor, HELIOS Clinics Erfurt, Institute of Pathology, Germany

11:05-11:25

Title: New Systemic and Targeted Therapies for Lung Cancer in Women
Dr. Marianna Koczywas, Assistant Professor, Department of Medical Oncology, City of Hope Comprehensive Cancer Center, USA

11:25-11:45

Title: Oncolytic Adenoviruses for Glioma Therapy
Dr. Hong Jiang, Assistant Professor, Department of Neuro-Oncology, M. D. Anderson Cancer Center, University of Texas, USA

11:45-12:05

Title: The Application of “Molecular Architecture” Strategy in Drug Discovery
-Total Synthesis and Process Development of Synthetic Epothilones
Dr. Yue Chen, Professor, College of Pharmacy, Nankai University, China

12:05-12:30

Title: Novel Therapies in Soft Tissue Sarcoma
Dr. Robin L Jones
, Medical Oncologist, Sarcoma Unit, Royal Marsden Hospital, UK

June 24, 2009
Wednesday
13:30-17:00

Track 3-9: Molecular Therapeutics of Cancer

Session Chair:
Dr. Joy Zhu, Senior Vice President, Global Clinical Development, S*BIO Pte Ltd., Singapore
Session Co-Chair:
Dr. Jie Wu, Senior Member and Professor, Department of Molecular Oncology, Lee Moffitt Cancer Center and Research Institute, USA

13:30-13:50

Keynote Speech:
Title: New Drug Development in Sarcoma: Exploration of Novel Targets, Particularly the Mammalian Target of Rapamycin (mTOR) Pathway
Dr.
Pierre Dodion,
Chief Medical Officer, ARIAD Pharmaceuticals, Inc., UK

13:50-14:10

Speech Opportunity Available

14:10-14:30

Title: A Phase 1 Study of SB939, An Oral HDAC Inhibitor, in Patients with Advanced Solid Malignancies
Dr. Joy Zhu,
Senior Vice President, Global Clinical Development, S*BIO Pte Ltd., Singapore

14:30-14:50

Title: New Insights on the Antitumoral Properties of Prodiginines
Dr. Ricardo Pérez-Tomás, Professor and Senior Group Leader, Cancer Cell Biology Research Group, Department of Cell Biology and Pathology, University of Barcelona, Spain

14:50-15:10

Title: Molecular Radiosensitization of Cancer by Modulating Cell Death Pathways
Dr.
Liang Xu,
Assistant Professor, University of Michigan Comprehensive Cancer Center, USA

15:10-15:25

Coffee Break

15:25-15:45

Title: Anti-tumor Activities of Histone Deacetylase Inhibitors against Cancer
Dr. Takashi Kumagai, Director of Hematology and Clinical Associate Professor, Tokyo Medical and Dental University; Physician and Researcher, Ohme Municipal General Hospital, Japan

15:45-16:05

Title: Targeting Shp2 Protein Tyrosine Phosphatase for Cancer Therapy
Dr. Jie Wu,
Senior Member and Professor, Department of Molecular Oncology, SRB-3 H., Lee Moffitt Cancer Center and Research Institute, USA

16:05-16:25

Title: Suppression of Breast Tumor Angiogenesis and Metastasis by P16 via Modulation of VEGF Expression
Dr. Yi Lu, Associate Professor, Department of Pathology and Department of Medicine College of Medicine University of Tennessee Health Science Center, USA

16:25-16:45

Title: Trans-splicing Ribozyme as a Multifunctional Cancer Gene Therapy Device
Dr. Sang-Jin Lee, Senior Scientist, Genitourinary Cancer Branch, National Cancer Center, Korea

16:45-17:05

Title: Targeting Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) as a New Strategy for Cancer Treatment
Dr. Ana B. Oton, Assistant Professor, University of Colorado, Denver Health Medical Center, USA

17:05-17:30

Title: Phenoxodiol Inhibits Plasma Membrane Electron Transport and Induces Apoptosis in Cancer Cells and Activated Lymphocytes
Dr. Patries Herst, Senior Lecturer, Department of Radiation Therapy, University of Otago, New Zealand

June 25, 2009
Thursday
08:30-12:00

Track 3-10: Anti-cancer Monoclonal Antibodies and Cancer Vaccines

Session Chair:

Dr. Mogens H.Claesson, CSO, DanDrit Biotech, Denmark

Session Co-Chair:

Dr. Thomas Kieber-Emmons, Professor of Pathology, Wilkins Chair in Breast Cancer Research, Director of Breast Cancer Research Development; Associate Director, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, USA

08:30-08:55

Keynote Speech:
Title: Anticancer Vaccine Development: The Carbohydrate Epitope Approach
Dr. Ouathek Ouerfelli,
Head, Organic Synthesis Core Laboratory, Memorial Sloan-Kettering Cancer Center, USA

08:55-09:20

Title: Dendritic Cell-based Cancer Vaccination in Patients with Advanced and Progressive Colorectal Cancer Using Lysate from an Allogenic MAGE Containing Tumor for Dendritic Cell Loading
Dr. Mogens H.Claesson,
CSO, DanDrit Biotech, Denmark

09:20-09:45

Title: The First Use of a Bioengineered Live Listeria monocytogenes Vaccine in Humans
Dr. John Rothman, VP of Science & Operations, Advaxis Inc, USA

09:45-10:10

Title: Development of New Therapeutic Vaccine Modalities
Dr. Mai-Britt Zocca, CEO, DanDrit Biotech, Denmark

10:10-10:25

Coffee Break

10:25-10:50

Title: CA215-based Anti-cancer Vaccines
Dr. Gregory Lee,
Professor and Director of Andrology Laboratory, The University of British Columbia, Canada

10:50-11:15

Title: Peptide Mimotopes as Prototypic Templates of Broad-spectrum Surrogates of Carbohydrate Antigens for Cancer Vaccination
Dr. Thomas Kieber-Emmons, Professor of Pathology, Wilkins Chair in Breast Cancer Research, Director of Breast Cancer Research Development; Associate Director, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, USA

11:15-11:40

Title: Therapeutic Proteins: Current Use in Oncology
Dr. Valentina Tzekova,
Professor, Head of Clinic of Chemotherapy and Radiotherapy, University Hospital Queen Joanna, Republic of Bulgaria

11:40-12:05

Speech Opportunity Available

12:05-12:30

Panel Discussion
3-5 Topics will be Proposed by Session Chair

Track 4: Diagnostics and Clinical Management
-Applying Right Ways to Rescue Lives

Time and Place

Co-Current Sessions and Activities

June 22, 2009
Monday
13:30-17:00

Track 4-1: Biomarkers for Cancer Predisposition, Screening and Prognosis

Session Chair:
Dr. Xiao-Feng Sun, Professor, Department of Oncology-, Institute of Clinical and Experimental Medicine, University of Linköping, Sweden
Session Co-Chair:

Dr. Subunit Chulso Moon, Founder and CEO of Cangen; Assistant Professor Department of Oncology, Otolaryngology, Head and Neck Surgery, The Johns Hopkins University School of Medicine, USA

13:30-13:50

Keynote Speech: Speech Opportunity Available

13:50-14:10

Title: Biomarkers Associated with Radiotherapy and Prognosis of Rectal Cancer Patients Participated in a Swedish Clinical Trial of Preoperative Radiotherapy
Dr. Xiao-Feng Sun, Professor, Department of Oncology, Institute of Clinical and Experimental Medicine, University of Linköping, Sweden

14:10-14:30

Title: Identification of Novel Protein with Antisense Activity to Human Telomerase Reverse Transcriptase Catalytic
Dr. Subunit Chulso Moon, Founder and CEO of Cangen; Assistant Professor Department of Oncology, Otolaryngology, Head and Neck Surgery, The Johns Hopkins University School of Medicine, USA

14:30-14:50

Title: Novel Oncofetal Protein Glypican 3 as a Diagnostic Marker of Cancers
Dr.
Ximing J. Yang,
Professor of Pathology and Director of Pathology Core Facility, Department of Pathology, Northwestern University Feinberg School of Medicine, USA

14:50-15:10

Title: Ensemble Clustering Algorithm Enhances TNM Prognostic Assessment in Lung Cancer
Dr. Dechang Chen,
Associate Professor, Division of Epidemiology and Biostatistics, Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, USA

15:10-15:25

Coffee Break

15:25-15:45

Title: Discovery and Validation of Biomarkers of Cisplatin Resistance in Human Ovarian Cancer Using Proteomics Approaches
Dr. Mu Wang, Assistant Professor and Director, Protein Analysis Research Center,  Indiana University; Vice President of Research and Development, Monarch LifeSciences, USA

15:45-16:05

Title: GTPase Mechanism of (Oncogenic) Ras Proteins at Atomic Detail
Dr. Klaus Gerwert,
Chair of Biophysics, Department of Biophysics, University of Bochum, Germany

16:05-16:25

Title: Shotgun LC/MS Proteomics of Breast Cancer Sera from African American Women
Dr. Padma Tadi-Uppala,
Associate Professor, Department of Environmental and Occupational Health, School of Public Health, Loma Linda University, USA

16:25-16:45

Title: Cardiac Troponins as Biomarkers of Cardiotoxicity of the Antineoplastic Agents
Dr. Michaela Adamcova, Associate Professor, Department of Physiology, Charles University, Czech Republic

16:45-17:05

Title: Application of 1h in Vivo MRS Spectra and Pattern Recognition Methods in Analysis of Normal-Appearing Cerebellar Tissue after Cerebellum Tumors Treatment
Dr. Maria Sokol,
Associate Professor, Comprehensive Cancer Center, Maria Sklodowska-Curie Memorial Institute, Branch Gliwice, Poland

17:05-17:25

Title: Expression of MicroRNAs in Endometrioid Adenocarcinoma
Dr.Yinmei Dai
, Chief Physician and Associate Professor, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China

June 23, 2009
Tuesday
08:30-12:00

Track 4-2: Molecular Diagnostics for Cancers

Session Chair:

Dr. Gary A. Clawson, Director, Gittlen Cancer Research Foundation; Professor, Department of Pathology and Biochemistry and Molecular Biology, The Materials Research Insitute, Pensylvania State Unviversity, Hershey Medical Center, USA

Session Co-Chair:

Dr. Hong Zhang, Professor of Tumor Biology, School of Life Sciences, University of Skövde, Sweden

08:30-08:50

Keynote Speech:
Title: Molecular Diagnosis: A Personalized Oncology Program Driven by Massively Sequencing and PAP
Dr. Steve S. Sommer
, Chair, Department of Molecular Diagnosis, City of Hope National Medical Center, USA

08:50-09:10

Title:: A Chip-based Nanomechanical Sensor for Detection of Circulating Tumor Cells and Markers
Dr. Gary A. Clawson, Director, Gittlen Cancer Research Foundation; Professor, Department of Pathology and Biochemistry and Molecular Biology, The Materials Research Insitute, Pensylvania State Unviversity, Hershey Medical Center, USA

09:10-09:30

Title: The Development of a Detection System as a Diagnostic Screening Test for Lung Cancer
Dr. Daniel S. Sitar,
Professor, Department of Internal Medicine (Clinical Pharmacology), University of Manitoba, Canada

09:30-09:50

Title: Rational Design Protein-based MRI Contrast Agents with High Relaxivity and Target Capability to Cancers
Dr. Jenny J. Yang,
Professor, Department of Chemistry, Center for Drug Design and Advanced Biotechnology, Georgia State University, USA

09:50-10:10

Speech Opportunity Available

10:10-10:25

Coffee Break

10:25-10:45

Title: Molecular Diagnosis in Colorectal Carcinoma
Dr. Hong Zhang,
Professor of Tumor Biology, School of Life Sciences, University of Skövde, Sweden

10:45-11:05

Title: MALDI-TOF Mass Spectrometry-based Serum Proteome Pattern Analysis in Molecular Diagnostics of the Early Stage Breast Cancer
Dr. Piotr Widlak, Professor, Department of Experimental and Clinical Radiobiology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland

11:05-11:25

Speech Opportunity Available

11:25-11:45

Title: The Power and Promise of DNA Methylation in Cervical Cancer Screening
Dr. Hung-Cheng Lai,
Associate Professor, Department of Ob/Gyn, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

11:45-12:05

Speech Opportunity Available

12:05-12:30

Panel Discussion
3-5 Topics will be Proposed by Session Chair

June 23, 2009
Tuesday
13:30-17:00

Track 4-3: Surgical Oncology, and Tumor Imaging Technologies

Session Chair:
Dr. Martin Leach, Director, Cancer Research UK and EPSRC Cancer Imaging Centre, Institute of Cancer Research and Royal Marsden Hospital, UK
Session Co-Chair:
Call for Co-Chair

13:30-13:50

Speech Opportunity Available

13:50-14:10

Title: Minimally Invasive Surgery for Hepatic Malignancies.
Dr. Baki Topal, Professor and Head of Clinics, Department of Surgery, University Hospital of Leuven, Belgium

14:10-14:30

Title: Functional Imaging of Cancer with PET: An Early View of Response
Dr. Val J. Lowe, Professor, Department of Radiology, Division of Nuclear Medicine, Mayo Clinic, Rochester, USA

14:30-14:50

Speech Opportunity Available

14:50-15:10

Title: Functional Imaging for Planning Cancer Therapy
Dr Martin O Leach,
Director, Section of Magnetic Resonance, Institute of Cancer Research and Royal Marsden Hospital, UK

15:10-15:25

Coffee Break

15:25-15:45

Speech Opportunity Available

15:45-16:05

Title: Multidisciplinary Treatment for Hepatocellular Carcinoma
Dr. Keiichi Kubota, Professor and Chairman, Department of Gastro-enterological Surgery, Dokkyo University School of Medicine, Japan

16:05-16:25

Title: Treatment for Advanced Pancreatic Cancer
Dr.
Mitsugi Shimoda,
Associate Professor, Second Department of Surgery, Dokkyo Medical University School of Medicine, Japan

16:25-16:45

Title: PET/CT-perfusion: Emerging Combined Clinical Protocols for Therapy Response Assessment
Dr. Patrick Veit-Haibach,
Department of Medical Radiology, Division of Nuclear Medicine, University Hospital Zuerich, Switzerland

16:45-17:05

Title: Bidding "Goodbye" to Drains Can be a Boon in BCT and Oncoplastic Surgery for Better Health Economics, and Quality of Life - Randomized Controlled Study
Dr. Thomas Varughese,
Chief, Cancer Division and Surgical Oncology, Chief Lake Shore Hospital & Research Centre, India

17:05-17:30

Panel Discussion
3-5 Topics will be Proposed by Session Chair

June 24, 2009
Wednesday
08:30-12:00

Track 4-4: Emerging Therapies and Treatment Options in Tumor
Session Chair:

Dr. Periasamy Selvaraj, Associate Professor, Department of Pathology Emory University, USA

Co-Chair:
Dr. Chen Liu, Professor, Dept. of Pathology, Immunology and Laboratory Medicine, University of Florida, USA

08:30-08:50

Keynote Speech:
Title:
Anticancer Drug Ukrain: Biological Properties and Clinical Results
Dr. Nowicky Wassil,
Managing Director, Nowicky Pharma, Austria

08:50-09:10

Speech Opportunity Available

09:10-09:30

Title: TRAIL Agonists as a Therapy for Liver Cancer
Dr. Chen Liu,
Professor, Dept. of Pathology, Immunology and Laboratory Medicine, University of Florida, USA

09:30-09:50

Title: Individualized Immunotherapies for Cancer: Challenges and Approaches
Dr. Periasamy Selvaraj, Associate Professor, Department of Pathology, Emory University, USA

09:50-10:10

Title: Management of Metastatic Renal Cell Cancer in the Elderly: Challenges and Opportunities
Dr. Jue Wang, Assistant Professor of Clinical Medicine, Section of Oncology and Hematology, University of Nebraska Medical Center, USA

10:10-10:25

Coffee Break

10:25-10:45

Speech Opportunity Available

10:45-11:05

Title: New Approaches to Treating Cancer Pain and the Tumor Itself: A Focus on Endothelin-1
Dr. Guy Hans,
Manager, Multidisciplinary Pain Center, Antwerp University Hospital (UZA), Edegem, Belgium

11:05-11:25

Title: Adaptation of Bacterial Cells to Antineoplastic Agents May Increase the Risk of Post-chemotherapy Infections
Dr. Carla de Carvalho,
Research Scientist, IBB-Institute for Biotechnology and Bioengineering, Centre for Biological and Chemical Engineering, Instituto Superior Técnico, Portugal

11:25-11:45

Title: The ERCC (Excision Repair Cross-complementation): Could It be a Novel Diagnostic/Therapeutic Predictor in HCC (Hepatocellular Carcinoma)
Dr.
Nazim S Turhal,
Professor, Department of Internal Medicine, Division of Oncology, Marmara University Hospital, Turkey

11:45-12:05

Title: Alpha 1 Thymosin for Cancer Vaccines
Dr. Gustavo Antonio Moviglia, Full Professor of Cellular Therapy and Director, Instituto Regina Mater, Maimónides University, Argentina

12:05-12:25

Panel Discussion
3-5 Topics will be Proposed by Session Chair

June 24, 2009
Wednesday
13:30-17:00

Track 4-5: Concomitant Chemotherapy and Radiotherapy: Theoretical Basis and Clinical Experience

Session Chair:
Dr. Nils Cordes, PI / Group Leader, Biological and Molecular Targeting OncoRay - Center for Radiation Research in Oncology, Medical Faculty Carl Gustav Carus, Dresden University of Technology, Fetscherstrasse, Germany

Session Co-Chair:

Dr. Lembit Sihver, Professor, Head of Nuclear Science and Engineering Group, Chalmers University of Technology, Nuclear Engineering, Applied Physics, Sweden

13:30-13:50

Keynote Speech:
Title:
Molecular Basis of Radiation-cis-platinum cross-resistance in a Human Ovarian Cancer Model
Dr.
Shirley Lehnert,
Professor, Department of Oncology, McGill University, Montreal, Canada

13:50-14:10

Title: Targeting Cell Adhesion Molecules plus Radiotherapy
Dr. Nils Cordes,
PI / Group Leader, Biological and Molecular Targeting OncoRay - Center for Radiation Research in Oncology, Medical Faculty Carl Gustav Carus, Dresden University of Technology, Fetscherstrasse, Germany

14:10-14:30

Title: Novel Radiation Strategies in the Treatment of Locally Advanced Rectal Cancer
Dr. William Blackstock
, Professor, Department of Radiation Oncology, Wake Forest University Baptist Medical Center, USA

14:30-14:50

Title: Single Fraction Intra-operative Radiotherapy Following Lumpectomy for Breast Cancer
Dr. Frederick M. Dirbas,
Associate Professor of Surgery, Division of General Surgery, Department of Surgery, Stanford University Medical Center, USA

14:50-15:10

Title: DNA Repair and the Tumor Microenvironment: New Targets and New Therapies
Dr. Robert Bristow,
Clinician-Scientist, Departments of Medical Biophysics and Radiation Oncology, University of Toronto and Ontario Cancer Institute and Princess Margaret Hospital (University Health Network), Toronto, Canada

15:10-15:25

Coffee Break

15:25-15:45

Title: TBD
Dr. Lembit Sihver,
Professor, Head of Nuclear Science and Engineering Group, Chalmers University of Technology, Nuclear Engineering, Applied Physics, Sweden

15:45-16:05

Title: A Rational Design of Anti-metastatic Treatment Inspired by the Mechanisms of the Reduced Aggressiveness of Tumors in the Aged
Dr. Judith Leibovici,
Professor, Department of Pathology, Sackler Faculty of Medicine, Tel- Aviv University, Israel

16:05-16:25

Title: Clinical Applications of Radiofrequency Ablation for Hepatocellular Carcinoma
Dr. Kelvin K.C. Ng, Consultant and Clinical Associate Professor Department of Surgery, The University of Hong Kong, Hong Kong, China

16:25-16:45

Title: Survivin as Potent Target in Radiooncology
Dr. Franz Roedel,
Head, Department of Radiation Therapy and Oncology, University of Frankfurt/Main, Frankfurt, Germany

16:45-17:05

Title: Modulating the Tumor Microenvironment to Improve Cancer Therapy
Dr. Amit Maity,
Associate Professor of Radiation, Department of Radiation Oncology, Amit Maity University of Pennsylvania School of Medicine, USA

17:05-17:30

Title: The Use of Poly(ADP)ribose Polymerase (PARP-1) Inhibitors in the Treatment of Cancer
Dr. Joseph A. De Soto, Assistant Professor, Laboratory of Translational Oncology, Department of Health, Injury, and Disease Management, Uniformed Services University of the Health Sciences, USA

June 25, 2009
Wednesday
8:30-12:00

Track 4-6: Psycho-Oncology, Nutritional Protection, Pain Management and End-of-Life Care

Session Chair:
Call for Host

Session Co-Chair:

Dr. Ozgur Ozyilkan, Professor of Medicine, Department of Medical Oncology, Baskent University Faculty of Medicine, Turkey

8:30-8:55

Title: Prevention and Early Detection on Breast Cancer
Dr. Tsu-Yin Wu,
Director, Healthy Asian Americans Project, University of Michigan; Associate Professor, School of Nursing, Eastern Michigan University, USA

8:55-9:20

Speech Opportunity Available

9:20-9:45

Title: End of Life Care and Religion in Oncology
Dr. Ozgur Ozyilkan,
Professor of Medicine, Department of Medical Oncology, Baskent University Faculty of Medicine, Turkey

9:45-10:10

Title: Management of Pain in Cancer Patients at End of Life
Dr. Nesrin Bozdogan,
Assistant Professor of Medicine, Department of Anestesiology and Reanimation, Baskent University Faculty of Medicine, Turkey

10:10-10:25

Coffee Break

10:25-10:50

Title: Malnutrition in Cancer Patients – Assessment and Treatments
Dr. Hans K Biesalski,
Professor, Department of Biological Chemistry and Nutrition, University of Hoheneim, Germany

10:50-11:15

Title: The Experiences in Facing Newly Diagnosis of Breast Cancer among Elderly Women in Taiwan
Dr. Hung-Ru Lin,
Associate Professor and Associate Dean, School of Nursing, National Taipei College of Nursing, Taipei, Taiwan

11:15-11:40

Title: Phytonutrients Support Estrogenic Activity in Bone Cells but Inhibit It in Breast Cancer Cells
Dr. Joseph Levy, Professor, Department of Clinical Biochemistry, Faculty of Health Sciences and Soroka Medical Center, Ben Gurion University, Israel

11:40-12:05

Title: Cancer and Quality of Life
Dr. Sibel Eyigor,
Associate Professor, Physical Therapy and Rehabilitation Department, Medical Faculty, Turkey

12:05-12:25

Panel Discussion
3-5 Topics will be Proposed by Session Chair

Workshop: Educational Workshops

Time and Place

Co-Current Sessions and Activities

June 23, 2009
Tuesday
08:30-12:00

Workshop 1 : How to publish in Top Journal ?

Session Chair:
Dr. Denys Wheatley, President of the International Federation for Cell Biology; Chairman and Director of BioMedES; Adjunct Professor, Wayne State Medical School, Detroit, USA; Full Foreign Member Ukrainian National Adaemy of Medical Sciences

8:30-9:20

Speech Opportunity Available

9:20-10:10

Title: How to Get Your Papers Published in the Best Journal
Dr. Frank J. Rauscher
, Editor-in-Chief, Cancer Research; Professor and Chairman, The Gene Expression and Regulation Program, Deputy Director, The Wistar Institute Cancer Center, The Wistar Institute, Philadelphia, USA

10:10-10:20

Coffee Break

10:20-11:10

Speech Opportunity Available

11:10-12:00

Title: TBD
Dr. Denys Wheatley,
President of the International Federation for Cell Biology, Chairman and Director of BioMedES, Adjunct Professor, Wayne State Medical School, Detroit, USA; Full Foreign Member Ukrainian National Academy of Medical Sciences

June 24, 2009
Wednesday
08:30-12:00

Workshop 2 : Careers for Students and Scientists

Session Chair:
Call for Host

8:30-9:20

Title: Scientific Input and Expertise needed for Successful Drug Discovery and Drug Development Teams in Large Pharma and Small Biopharmaceutical Companies
Dr. Robert Sigler, Head of Pathology and Toxicology, Avidimer Therapeutics Inc., MI USA

9:20-10:10

Speech Opportunity Available

10:10-10:20

Coffee Break

10:20-11:10

Speech Opportunity Available

11:10-12:00

Speech Opportunity Available

 
 

© 2009 All right reserved for BIT Life Sciences
Contact Us:Tel: 0086-411-84799609, Fax: 0086-411-84799629